The Toxicology of Hydroquinone — Relevance to Occupational and Environmental Exposure

References

• International Programme on Chemical Safety (IPCS), Environmental Health Criteria 157: Hydro- quinone, Geneva: World Health Organization, 1994.
   Google Scholar
• Hazardous Substance Data Bank (HSDB), Entry for Hydroquinone, Bethesda: National Library of Medicine, 1997.
   Google Scholar
• Krumenacker, L., Constantini, M., Pontal, P., and Sentenac, J., Hydroquinone, resorcinol, and catechol. In: Howe-Grant, M. Ed. Encyclopedia of Chemical Technology, Vol. 13. John Wiley & Sons, New York. 1995, 996–1014.
   Google Scholar
• National Institute of Occupational Safety and Health (NIOSH), National Occupational Exposure Survey (NOES), Cincinnati, NIOSH, 1982.
   Google Scholar
• Deisinger, P. J., Hill, T. S., and English, J. C.,Human exposure to naturally occurring hydroquinone, J. Toxicol. Environ. Health 47, 101–116, 1996.
   Google Scholar
• Leanderson, P. and Tagesson, C., Cigarette smoke- induced DNA-damage: role of hydroquinone and cat- echol in the formation of the oxidative DNA-adduct, 8-hydroxydeoxyguanosine, Chem.-Biol. Interact. 75, 71–81, 1990.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program (NTP), Toxicology and Carcinogenesis Studies of Hydroquinone in F- 344/N Rats and B6C3F1 Mice, NTP Technical Report No. 366; Washington, U.S. Department of Health and Human Services, 1989.
   Google Scholar
• International Agency for Research on Cancer (IARC), Monographs on the Evaluation of the Carci- nogenic Risk of Chemicals to Man; Overall Evalua- tions of Carcinogenicity: An Updating of IARC Mono- graphs Volumes 1 to 42, Lyon: IARC, 1987, 64.
   Google Scholar
• American Conference of Governmental Industrial Hygienists (ACGIH), 1997–1998 Threshold Limit Values (TLVs) for Chemical Substances and Physical Agents, Cincinnati: ACGIH, 1997.
   Google Scholar
• Hard, G. C., Whysner, J., English, J. C., Zang, E., and Williams, G. M., Relationship of hydroquinone- associated rat renal tumors with spontaneous chronic progressive nephropathy, Toxicol. Pathol. 25, 132– 143, 1997.
   PubMed Web of Science ®Google Scholar
• Whysner, J., Verna, L., English, J. C., and Will- iams, G. M., Analysis of studies related to tumorige- nicity induced by hydroquinone, Regul. Toxicol. Pharmacol. 21, 158–176, 1995.
   PubMed Web of Science ®Google Scholar
• Cosmetic, Toiletry, and Fragrance Association (CTFA), Addendum to the final report on the safety assessment of hydroquinone, J. Am. Coll. Toxicol. 13: 167–230, 1994.
   Google Scholar
• Cosmetic, Toiletry, and Fragrance Association (CTFA), Final report on the safety assessment of hydroquinone and pyrocatechol, J. Am. Coll. Toxicol. 5, 123–165, 1986.
   Google Scholar
• Devillers, J., Boule, P., Vasseur, P., Prevot, P., Steiman, R., Seigle-Murandi, F., Benoit-Guyod,J. L., Nendza, M., Grionin, C., Dive, D., and Chambon, P., Environmental and health risks of hy- droquinone, Ecotoxicol. Environ. Safety 19, 327–354, 1990.
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency (USEPA), Health and Environmental Effects Docu- ment for p-Hydroquinone, Cincinnati, Environmental Criteria and Assessment Office, USEPA, 1987.
   Google Scholar
• O’Donoghue, J. L., Richardson, D. P., and Dyer,W. M., Hydroquinone and hepatitis, Lancet 346, 1427– 1428, 1995.
   Web of Science ®Google Scholar
• Oglesby, F. L., Sterner, J. H., and Anderson, B., Quinone vapors and their harmful effects. II. Plant exposures associated with eye injuries, J. Ind. Hyg. Toxicol. 29, 74–84, 1947.
   PubMedGoogle Scholar
• Friedlander, B. R., Hearne, F. T., and Newman,B. J., Mortality, cancer incidence, and sickness-ab- sence in photographic processors: an epidemiologic study, J. Occup. Med. 24, 605–613, 1982.
   PubMedGoogle Scholar
• Barber, E. D., Hill, T., and Schum, D. B., The percutaneous absorption of hydroquinone (HQ) through rat and human skin in vitro, Toxicol. Lett. 80, 167–172, 1995.
   PubMed Web of Science ®Google Scholar
• O’Donoghue, J. L., Eastman Kodak Corp., Occupa- tional Medicine and Hygiene Laboratories, United Kingdom Health and Safety Executive, London, U.K., unpublished data, 1993.
   Google Scholar
• Semenza, G., Bircher, J., Mulhaupt, E., Koide, T., Pfenninger, E., Marthaler, T., Gmunder, U., and Haemmerli, U. P., Arbutin absorption in human small intestine: a simple procedure for the determination of active sugar uptake in peroral biopsy specimens, Clin. Chim. Acta 25, 213–219, 1969.
   PubMed Web of Science ®Google Scholar
• Inoue, O., Seiji, K., Nakatsuka, H., Watanabe, T., Yin, S-N., Li, G-L., Cai, S-X., Jin, C., and Ikeda, M., Excretion of 1,2,4–benzenetriol in the urine of workers exposed to benzene, Br. J. Ind. Med. 46, 559– 565, 1989.
   PubMedGoogle Scholar
• Bechtold, W. E., Sun, J. D., Birnbaum, L. S., Yin,S. N., Li, G. L., Kasicki, S., Lucier, G., and Henderson, R. F., S-Phenylcysteine formation inhemoglobin as a biological exposure index to ben- zene, Arch. Toxicol. 66, 303–309, 1992.
   PubMed Web of Science ®Google Scholar
• Sterner, J. H., Ames, S., and Fassett, D. W., Com- parison of acute toxicity of hydroquinone and some related di and trihydroxy benzenes, Fed. Proc. 8, 334(abstract), 1949.
   Google Scholar
• Woodard, G. D. L., The Toxicity, Mechanism of Action, and Metabolism of Hydroquinone. Washing- ton, George Washington University, Dissertation the- sis, 1951.
   Google Scholar
• Carlson, A. J. and Brewer, N. R., Toxicity studies on hydroquinone, Proc. Soc. Exp. Biol. Med. 84, 684– 688, 1953.
   PubMed Web of Science ®Google Scholar
• Christian, R. T., Clark, C. S., Cody, T. E., Whiterup, S., Gartside, P. S., Elia, V. J., Eller, P. M., Lingg, R., and Cooper, G. P., The Development of a Test for the Potability of Water Treated by a Direct Reuse System. University of Cincinnati, Cincinnati, Ohio, Washington: U.S. Army Medical Research and De- velopment Command, Contract No. DADA-17–73– C-3013, 1976.
   Google Scholar
• Dutton, G. J. and Greig, C. G., Observations on the distribution of glucuronide synthesis in tissues, Biochem. J. 66: 52P(abstract), 1957.
   Google Scholar
• Hartiala, K. J., Studies on detoxication mechanisms.III. Glucuronide synthesis of various organs with speacial reference to the detoxifying capacity of the mucous membrane of the alimentary canal, Ann. Med. Exp. Fenn. 33, 239–245, 1955.
   PubMedGoogle Scholar
• Registry of Toxic Effects of Chemical Substances (RTECS), Entry for Hydroquinone, Cincinnati, Na- tional Institute of Occupational Safety and Health, 1998.
   Google Scholar
• Nomiyama, K., Minai, S. T., and Kita, H., Studies on poisoning by benzene and its homologues: median lethal doses of benzene metabolites, Ind. Health 5, 143–148, 1967.
   Google Scholar
• Brieger, L., On the knowledge of the physiological behavior of catechol, hydroquinone and resorcinol and their formation in the animal organism (German), Dubois Arch. Physiol. S61, 1879.
   Google Scholar
• Topping, D. C., Subchronic Oral Toxicity Study of Hydroquinone in Rats Utilizing a Functional-Obser- vational Battery and Neuropathology to Detect Neu- rotoxicity, TSCATS Database, EPA/OTS Doc #40– 8869294, NTIS/OTS0516694, 1988.
   Google Scholar
• Angel, A. and Rogers, K. J., Convulsant activity of polyphenols, Nature, 217, 84–85, 1968.
   PubMed Web of Science ®Google Scholar
• Angel, A. and Rogers, K. J., An analysis of the convulsant activity of substituted benzenes in the mouse, Toxicol. Appl. Pharmacol. 21, 214–229, 1972.
   PubMed Web of Science ®Google Scholar
• Otsuka, M. and Nonomura, Y., The action of phe- nolic substances on motor nerve endings, J. Pharmacol. Exp. Ther. 140, 41–45, 1963.
   PubMed Web of Science ®Google Scholar
• Mogey, G. A. and Young, P. A., The antagonism of curarizing activity by phenolic substances, Br. J. Pharmacol. 4, 359–365, 1949.
   Web of Science ®Google Scholar
• Chambers, P. L. and Rowan, M. J., An analysis of the toxicity of hydroquinone on central synaptic trans- mission, Toxicol. Appl. Pharmacol. 54, 238–243, 1980.
   PubMed Web of Science ®Google Scholar
• Mitchell, A. and Webster, J., Notes on a case of poisoning by hydroquinone, Br. Med. J. 21, 465, 1919.
   Google Scholar
• Rémond, A. and Colombies, H., Intoxication with hydroquinone (French), Ann. Méd. Lég. 7, 79–81, 1927.
   Google Scholar
• Guyot, H. J., Bchelier-Notter, J., and Tiffeneau, J., A case of fatal poisoning from hydroquinone (French), Ann. Méd. Lég. 46, 177–178, 1966.
   Google Scholar
• Hooper, R. R. and Husted, S. R., A shipboard out- break of gastroenteritis: Toxin in the drinking water, Military Med. 144, 804–807, 1979.
   PubMed Web of Science ®Google Scholar
• Halbron, P., Bosquet, A., and Tiffeneau, J., Fatal poisoning from a photographic developer (French), Bull. Mem. Soc. Med. Hop. Paris 55, 1596–1601, 1931.
   Google Scholar
• Busatto, S., Fatal poisoning from photographic de- veloper containing hydroquinone (German), Deutsch. Ztschr. Ges. Gerichtl. Med. 31, 285–297, 1939.
   Google Scholar
• Zeidman, I. and Deutl, R., Poisoning by hydro- quinone and mono-methyl-paraminophenol sulfate, Am. J. Med. Sci. 210, 328–333, 1945.
   Web of Science ®Google Scholar
• Saito, T., Kojimahara, M., Aoki, K., and Takeichi, S., Detection of hydroquinone in a poisoning case, J. Forensic Sci. 39, 266–270, 1994.
   PubMed Web of Science ®Google Scholar
• DiVincenzo, G. D., Hamilton, M. L., Reynolds,R. C., and Ziegler, D. A., Fate and Disposition of [U- 14C]Hydroquinone in Rats, TSCATS Database, EPA/ OTS Doc #40–7969029, NTIS/OTS0517792, 1979.
   Google Scholar
• DiVincenzo, G. D., Hamilton, M. L., Reynolds, R. C., and Ziegler, D. A., Metabolic fate and dispo- sition of [14C]hydroquinone given orally to Sprague- Dawley rats, Toxicology, 33, 9–18, 1984.
   PubMed Web of Science ®Google Scholar
• Lockhart, H. B., Fox, J. A., and DiVincenzo, G. D., The Metabolic Fate of [U-14C]Hydroquinone Admin- istered by Gavage to Male Fischer 344 Rats, TSCATS Database, EPA/OTS Doc #878214473, NTIS/ OTS206577, 1984.
   Google Scholar
• Fox, J. A., English, J. C., and Lockhart, H. B., Blood Elimination Kinetics of [U-14C]Hydroquinone Administered by Intragastric Intubation, Intratracheal Instillation or Intravenous Injection to Male Fischer 344 Rats, Rochester, NY, Health and Environment Laboratories; Eastman Kodak Company, 1986, Re- port No. TX-86–1.
   Google Scholar
• English, J. C., Deisinger, P. J., Perry, L. G., Schum,D. B., and Guest, D., Toxicokinetics Studies with Hydroquinone in Male and Female Fischer 344 Rats, TSCATS Database, EPA/OTS Doc #40–8869295, NTIS/OTS0516692, 1988.
   Google Scholar
• Saito, T. and Takeichi, S., Experimental studies on the toxicity of lithographic developer solution, Clin. Toxicol. 33, 343–348, 1995.
   Web of Science ®Google Scholar
• Lockhart, H. B., The Metabolic Fate of [14C]Hydro- quinone Administered by Intratracheal Instillation to Male Fischer 344 Rats, Rochester, NY, Health and Environment Laboratories; Eastman Kodak Company, 1985, Report No. TX-85–76
   Google Scholar
• Deisinger, P. J. and English, J. C., Bioavailability and Pulmonary Metabolism of Hydroquinone Follow- ing Intratrachael Instillation, Rochester, NY, Health and Environment Laboratories, Eastman Kodak Com- pany, 1997.
   Google Scholar
• Marty, J. P., Trouvin, J. H., Jacquot, C., and Wepierre, J., Rate of percutaneous pharmacokinetics of 14C-hydroquinone, Compt. Rend. Cong. Eur. Biopharm. Pharmaco. 2, 221–228, 1981.
   Google Scholar
• Marzulli, F. N., Brown, D. W. C., and Maibach,H. I., Techniques for studying skin penetration, Toxicol. Appl. Pharmacol. 3, 76–83, 1969.
   Google Scholar
• Hamilton, M. L., Guest, D., and DiVincenzo, G. D., The Percutaneous Absorption of [U-14C]Hydroquinone in Beagle Dogs, TSCATS Database, EPA/OTS Doc #40–8569237, NTIS/OTS0518004, 1985.
   Google Scholar
• Bucks, D. A., McMaster, J. R., Guy, R. H., and Maibach, H. I., Percutaneous absorption of hydro- quinone in humans: effect of 1–dodecylazacyclo-hep- tane-2–one (azone) and the 2–ethylhexyl ester of 4– (dimethylamino)benzoic acid (Escalol 507), J. Toxicol. Environ. Health 24, 249–289, 1988.
   Google Scholar
• Lehman, P. A. and Franz, T. J., Percutaneous ab- sorption of hydroquinone in human, pig, monkey and baboon in vitro. Proceedings: Society for Investiga- tive Dermatology, Baltimore; 1992 (abstract).
   Google Scholar
• Wester, R. C., Melendres, J., Hui, X. Y., Cox, R., Serranzana, S., Zhai, H. B., Quan, D. Y., and Maibach, H. I., Human in vivo and in vitro hydro- quinone topical bioavailability, metabolism, and dis- position, J. Toxicol. Environ. Health 54, 301–317, 1998.
   PubMed Web of Science ®Google Scholar
• Hill, T. S., Morgott, D. A., and English, J. C., Tissue-to-plasma partition coefficients (PCS) for hy- droquinone (HQ) in male Fischer and Sprague-Dawley rats, Fundam. Appl. Toxicol. 30, 39–40, 1996.
   PubMedGoogle Scholar
• Greenlee, W. F., Gross, E. A., and Irons, R. D., Relationships between benzene toxicity and the dis- position of 14C-labeled benzene metabolites in the rat, Chem.-Biol. Interact. 33, 285–299, 1981.
   PubMed Web of Science ®Google Scholar
• Greenlee, W. F., Sun, J. D., and Bus, J. S., A proposed mechanism of benzene toxicity: Formation of reactive intermediates from polyphenol metabo- lites, Toxicol. Appl. Pharmacol. 59, 187–195, 1981.
   PubMed Web of Science ®Google Scholar
• Subrahmanyam, V. V., Doane-Setzer, P., Steinmetz, K. L., Ross, D., and Smith, M. T., Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in ben- zene myelotoxicity, Toxicology 62, 107–116, 1990.
   PubMed Web of Science ®Google Scholar
• Legathe, A., Hoener, B., and Tozer, T. N., Pharma- cokinetic interaction between benzene metabolites, phenol and hydroquinone, in B6C3F1 mice, Toxicol. Appl. Pharmacol. 124, 131–138, 1994.
   PubMed Web of Science ®Google Scholar
• Garton, G. A. and Williams, R. T., Studies in detoxi- cation. XXI. The fates of quinol and resorcinol in the rabbit in relation to the metabolism of benzene, Biochem. J. 44, 234–238, 1949.
   Web of Science ®Google Scholar
• Nerland, D. E. and Pierce, W. M. J., Identification of N-acetyl-S-(2,5–dihydroxyphenyl)-L-cysteine as a urinary metabolite of benzene, phenol, and hydro- quinone, Drug Metab. Disp. 18, 958–961, 1990.
   PubMed Web of Science ®Google Scholar
• Hill, B. A., Kleiner, H. E., Ryan, E. A., Dulik,D. M., Monks, T. J., and Lau, S. S., Identification of multi-S-substituted conjugates of hydroquinone by HPLC-colorimetric electrode array analysis and mass spectroscopy, Chem. Res. Toxicol. 6, 459–469, 1993.
   PubMed Web of Science ®Google Scholar
• Gut, I., Nedelcheva, V., Soucek, P., Stopka, P., Vodicka, P., Gelboin, H. V., and Ingelman- Sundberg, M., The role of CYP2E1 and 2B1 in meta- bolic activation of benzene derivatives, Arch. Toxicol. 71, 45–56, 1996.
   PubMed Web of Science ®Google Scholar
• Lau, S. S., Sawalha, A. F., Halpert, J. R., Koop,D. R., and Monks, T. J., Cytochrome P450 catalyzed oxidation of hydroquinone in rodent and human mi- crosomes, Toxicologist 36, 23(abstract), 1997.
   Google Scholar
• Corley, R. A., English, J. C., and Morgott, D. A., A physiologically based pharmacokinetic model for hy- droquinone, Toxicol. Sci. 1–S, 141(abstract), 1998.
   Google Scholar
• Seaton, M. J., Schlosser, P. M., and Medinsky,M. A., In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity, Carcinogenesis 16, 1519–1527, 1995.
   PubMed Web of Science ®Google Scholar
• Cappiello, M., Giuliani, L., and Pacifici, G. M., Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mu- cosa, Pharmacology 40, 69–76, 1990.
   PubMed Web of Science ®Google Scholar
• Cassidy, M. K. and Houston, J. B., In vivo capacity of hepatic and extrahepatic enzymes to conjugate phe- nol, Drug Metab. Disp. 12, 619–624, 1984.
   PubMed Web of Science ®Google Scholar
• Jeftic, L. and Manning, G., A survey on the electro- chemical reduction of quinones, J. Electroanal. Chem. 26, 195–200, 1970.
   Google Scholar
• Finley, K. T., The addition and substitution chemistry of quinones. In: Patai, S., Ed., The Chemistry of the Quinoid Compounds, Part II. Wiley, London, 1974, 878–1144.
   Google Scholar
• Peter, M. G., Chemical modifications of biopolymers by quinones and quinone methides, Angew. Chem. Int. Ed. 28, 555–570, 1989.
   Web of Science ®Google Scholar
• Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., and Graham, D. G., Quinone chemistry and tox- icity, Toxicol. Appl. Pharmacol. 112, 2–16, 1992.
   PubMed Web of Science ®Google Scholar
• Smith, M. T., Evans, C. G., Thor, H., and Orrenius, S., Quinone induced oxidative injury to cells and tis- sues. In: Sies, H. Ed. Oxidative Stress, Academic Press, London, 1985, 91–113.
   Google Scholar
• O’Brien, P. J., Molecular mechanisms of quinone cytotoxicity, Chem.-Biol. Interact. 80, 1–41, 1991.
   PubMed Web of Science ®Google Scholar
• Schlosser, M. J., Shurina, R. D., and Kalf, G. D., Metabolism of phenol and hydroquinone to reactive products by macrophage peroxidase or purified pros- taglandin H synthase, Environ. Health Perspect. 82, 229–237, 1989.
   PubMed Web of Science ®Google Scholar
• Munday, R., Inhibition of naphthohydroquinone au- toxidation by DT-diaphorase (NAD(P)H:[quinone acceptor]oxidoreductase), Redox Report 3, 189–196, 1997.
   PubMed Web of Science ®Google Scholar
• Schlosser, M. J. and Kalf, G. F., Metabolic activa- tion of hydroquinone by macrophage peroxidase, Chem.-Biol. Interact. 72, 191–207, 1989.
   PubMed Web of Science ®Google Scholar
• Boatman, R. J., Perry, L. G., Fiorica, L. A., Polvino,J. M., and English, J. C., Quantification of covalentprotein adducts of hydroquinone in the blood and kidneys of rats, Toxicologist 14, 74(abstract), 1994.
   Google Scholar
• Ekström, T., Warholm, M., Kronevi, T., and Högberg, J., Recovery of malondialdehyde in urine as a 2,4–dinitrophenylhydrazine derivative after ex- posure to chloroform or hydroquinone, Chem.-Biol. Interact. 67, 25–31, 1988.
   PubMed Web of Science ®Google Scholar
• Stenius, U. and Högberg, J., -Glutamyltranspepti-dase-conferred resistance to hydroquinone induced GSH depletion and toxicity in isolated hepatocytes, Carcinogenesis 9, 1223–1227, 1988.
   PubMed Web of Science ®Google Scholar
• Nakagawa, Y. and Moldeu, P., Cytotoxic effects of phenyl-hydroquinone and some hydroquinones on isolated rat hepatocytes, Biochem. Pharmacol. 44, 1059–1065, 1992.
   PubMed Web of Science ®Google Scholar
• English, J. C., Deisinger, P. J., Hill, T., and Perry,L. G., Measurement of glutathione and cysteine in the kidneys of rats after oral treatment with hydroquinone, Int. Toxicol. 11–PF-6(abstract), 1995.
   Google Scholar
• Okazaki, S., Hoshiya, T., Takahashi, S., Futakuchi, M., Saito, K., and Hirose, M., Modification of hepato- and renal carcinogenesis by catechol and its isomers in rats pretreated with N-ethyl-N-hydroxyethylnitros- amine, Teratogen. Carcinogen. Mutagen. 13, 127– 137, 1993.
   PubMedGoogle Scholar
• Ganousis, L. G., Goon, D., Zyglewska, T., Wu,K. K., and Ross, D., Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolites, Mol. Pharma- col. 42, 1118–1125, 1992.
   PubMed Web of Science ®Google Scholar
• Epe, B., Harttig, U., Stopper, H., and Metzler, M., Covalent binding of reactive estrogen metabolites to microtubular protein as a possible mechanism of aneu- ploidy induction and neoplastic cell transformation, Environ. Health Perspect. 88, 123–127, 1990.
   PubMed Web of Science ®Google Scholar
• Fiorica, L. A., Hill, T. S., Morgott, D. A., and English, J. C., The plasma protein binding of hydro- quinone (HQ) in rats and humans, Toxicologist 30, 40(abstract), 1996.
   Google Scholar
• McDonald, T. A., Waidyanatha, S., and Rappaport,S. M., Measurement of adducts of benzoquinone with hemoglobin and albumin, Carcinogenesis 14, 1927– 1932, 1993.
   PubMed Web of Science ®Google Scholar
• Waidyanatha, S., Yeowelloconnell, K., and Rappaport, S. M., A new assay for albumin and hemoglobin adducts of 1,2– and 1,4–benzoquinones, Chem.-Biol. Interact. 115, 117–139, 1998.
   PubMed Web of Science ®Google Scholar
• McDonald, T. A., Yeowell-O’Connell, K., and Rappaport, S. M., Comparison of protein adducts of benzene oxide and benzoquinone in the blood and bone marrow of rats and mice exposed to [14C/ 13C]benzene, Cancer Res. 54, 4907–4914, 1994.
   PubMed Web of Science ®Google Scholar
• Frantz, C. E., Chen, H., and Eastmond, D. A., Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites, Environ. Health Perspect. 104, 1319–1323, 1996.
   PubMed Web of Science ®Google Scholar
• Schwartz, C. S., Snyder, R., and Kalf, G. F., The inhibition of mitochondrial DNA replication in vitro by the metabolites of benzene, hydroquinone andp-benzoquinone, Chem.-Biol. Interact. 53, 327–350,1985.
   PubMed Web of Science ®Google Scholar
• Soucek, P., Filipcova, B., and Gut, I., Cytochrome P450 destruction and radical scavenging by benzene and its metabolites, Biochem. Pharmacol. 47, 2233– 2242, 1994.
   PubMed Web of Science ®Google Scholar
• Gut, I., Nedelcheva, V., Soucek, P., Stopka, P., and Tichavská, B., Cytochromes P450 in benzene me- tabolism and involvement of their metabolites and reactive oxygen species in toxicity, Environ. Health Perspect. 104, 1211–1218, 1996.
   PubMed Web of Science ®Google Scholar
• Rushmore, T., Snyder, R., and Kalf, G., Covalent binding of benzene and its metabolites to DNA in rabbit bone marrow mitochondria in vitro, Chem.- Biol. Interact. 49, 133–154, 1984.
   PubMed Web of Science ®Google Scholar
• Kalf, G. F., Snyder, R., and Rushmore, T. H., Inhi- bition of RNA synthesis by benzene metabolites and their covalent binding to DNA in rabbit bone marrow mitochondria in vitro, Am. J. Ind. Med. 7, 485–492, 1985.
   PubMed Web of Science ®Google Scholar
• Jowa, L., Witz, G., Snyder, R., Winkle, S., and Kalf, G. F., Synthesis and characterization of deoxyguanosine-benzoquinone adducts, J. Appl. Toxicol. 10, 47–54, 1990.
   PubMed Web of Science ®Google Scholar
• Pathak, D. N., Lévay, G., and Bodell, W. J., DNA adduct formation in the bone marrow of B6C3F1 mice treated with benzene, Carcinogenesis 16, 1803–1808, 1995.
   Google Scholar
• Reddy, M. V., Blackburn, G. R., Irwin, S. E., Kommineni, C., Mackerer, C. R., and Mehlman,M. A., A method for in vitro culture of rat zymbal gland: use in mechanistic studies of benzene carcino- genesis in combination with 32P-postlabeling, Environ. Health Perspect. 82, 239–247, 1989.
   PubMed Web of Science ®Google Scholar
• Levay, G., Pongracz, K., and Bodell, W. J., Detec- tion of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabeling, Carcinogenesis, 12, 1181–1186, 1991.
   PubMed Web of Science ®Google Scholar
• Levay, G. and Bodell, W. J., Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites, Proc. Nat. Acad. Sci. U.S.A. 89, 7105–7109, 1992.
   PubMed Web of Science ®Google Scholar
• Bodell, W. J., Lévay, G., and Pongracz, K., Inves- tigation of benzene-DNA adducts and their detection in human bone marrow, Environ. Health Perspect. 99, 241–244, 1993.
   PubMed Web of Science ®Google Scholar
• Hedli, C. C., Rao, N. R., Reuhl, K. R., Witmer,C. M., and Snyder, R., Effects of benzene metabolite treatment on granulocytic differentiation and DNA adduct formation in HL-60 cells, Arch. Toxicol. 70, 135–144, 1996.
   PubMed Web of Science ®Google Scholar
• Levay, G. and Bodell, W. J., Role of hydrogen per- oxide in the formation of DNA adducts in HL-60 cells treated with benzene metabolites, Biochem. Biophys. Res. Comm. 222, 44–49, 1996.
   PubMed Web of Science ®Google Scholar
• Pongracz, K. and Bodel, W. J., Synthesis of N 2–(4- hydroxyphenyl)-2-deoxyguanosine 3-phosphate: comparison by 32P-postlabeling with the DNA adduct formed in HL-60 cells treated with hydroquinone, Chem. Res. Toxicol. 9, 593–598, 1996.
   PubMed Web of Science ®Google Scholar
• Kolachana, P., Subrahmanyam, V. V., Meyer, K. B., Zhang, L., and Smith, M. T., Benzene and its phe- nolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo, Cancer Res. 53, 1023–1026, 1993.
   PubMed Web of Science ®Google Scholar
• Schlosser, M. J., Shurina, R. D., and Kalf, G. D., Prostaglandin H synthase catalyzed oxidation of hyd- roquinone to a sulfhydryl-binding and DNA-damag- ing metabolite, Chem. Res. Toxicol. 3, 333–339, 1990.
   PubMed Web of Science ®Google Scholar
• Reddy, M. V., Bleicher, W. T., Blackburn, G. R., and Mackerer, C. R., DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1–enhanced 32P-postlabeling of adducts as labeled nucleoside biphosphates, dinucleotides and nucleoside monophosphates, Carcinogenesis 11, 1349– 1357, 1990.
   PubMed Web of Science ®Google Scholar
• English, J. C., Perry, L. G., Vlaovic, M., Moyer, C., and O’Donoghue, J. L., Measurement of nuclear DNA modification by 32P-postlabeling in the kidney of male and female Fischer 344 rats after multiple gavage doses of hydroquinone, Fundam. Appl. Toxicol. 23, 391–396.
   Google Scholar
• Reddy, M. V., Hill, T., O’Donoghue, J. L., and English, J. C., Lack of oxidative DNA damage by hydroquinone in the kidneys of rats after oral admin- istration, Proc. Am. Assoc. Cancer Res. 38, 78(ab- stract), 1997.
   Google Scholar
• Cho, D. H., Hong, J. T., Chin, K., Cho, T. S., and Lee, B. M., Organotropic formation and disappear- ance of 8-hydroxydeoxyguanosine in the kidney of Sprague-Dawley rats exposed to Adriamycin and KBrO3, Cancer Lett. 74, 141–145, 1993.
   PubMed Web of Science ®Google Scholar
• Brusick, D., Mutagenic Evaluation of Compound 75–151 (HQ). LBI Project #2547, Kensington, Maryland: Litton Bionetics, Inc. 1975.
   Google Scholar
• Cotruvo, J. A., Simmon, V. F., and Spanggord,R. J., Investigation of mutagenic effects of products of ozonation research in water, Ann. N.Y. Acad. Sci. 298, 124–140, 1978.
   PubMedGoogle Scholar
• Epler, J. L., Larimer, F. W., Rao, T. K., Nix, C. E., and Ho, T., Energy-related pollutants in the environ- ment: use of short-term tests for mutagenicity in the isolation and identification of biohazards, Environ. Health Perspect. 27, 11–20, 1978.
   PubMed Web of Science ®Google Scholar
• Florin, I., Rutberg, L., Curvall, M., and Enzell,C. R., Screening of tobacco smoke constituents for mutagenicity using the Ames test, Toxicology 15, 219– 232, 1980.
   PubMed Web of Science ®Google Scholar
• Haworth, S., Lawlor, T., Mortelmans, K., Speck, W., and Zeiger, E., Salmonella mutagenicity test results for 250 chemicals, Environ. Mutagen. 5, 1– 142, 1983.
   PubMedGoogle Scholar
• Sakai, M., Yoshida, D., and Mizusaki, S., Mutage- nicity of polycyclic aromatic hydrocarbons and quino- nes on Salmonella typhimurium TA97, Mutat. Res. 156, 61–67, 1985.
   PubMed Web of Science ®Google Scholar
• Rossman, T. G., Klein, C. B., and Snyder, C. A., Mutagenic metabolites of benzene detected in the microscreen assay, Environ. Health Perspect. 81, 77– 79, 1989.
   PubMed Web of Science ®Google Scholar
• Glatt, H., Padykula, R., Berchtold, G. A., Ludewig, G., Platt, K. L., Klein, J., and Oesch, F., Multiple activation pathways of benzene leading to products with varying genotoxic characteristics, Environ. Health Perspect. 82, 81–89, 1989.
   PubMed Web of Science ®Google Scholar
• Gocke, E., King, M.-T., Eckhardt, K., and Wild, D., Mutagenicity of cosmetics ingredients licensed by the European Community, Mutat. Res. 90, 91–109, 1981.
   PubMed Web of Science ®Google Scholar
• Murphy, S. and Serva, R., Lack of Mutagenicity of Hydroquinone (HQ), Tetramethylthiuram Monosulfide (TMTM), and Tetramethylthiuram Disulfide (TMTD), TSCATS Database, EPA/OTS Doc #88–920005216, NTIS/OTS0544190, 1992.
   Google Scholar
• Gocke, E., Wild, D., Eckhardt, K., and King, M.- T., Mutagenicity studies with the mouse spot test, Mutat. Res. 117, 201–212, 1983.
   PubMedGoogle Scholar
• Krasavage, W. J., Hydroquinone: A Dominant Le- thal Assay in Male Rats, TSCATS Database, EPA/ OTS Doc #878214709, NTIS/OTS206628, 1984.
   Google Scholar
• Wild, D., King, M.-T., Eckhardt, K., and Gocke, E., Mutagenic activity of aminophenols and diphenols, and relations with chemical structure, Mutat. Res. 85, 456(abstract), 1981.
   Google Scholar
• Lin, J. K. and Lee, S. F., Enhancement of the mu- tagenicity of polyphenols by chlorination and nitrosation in Salmonella typhimurium, Mutat. Res. 269, 217–224, 1992.
   PubMed Web of Science ®Google Scholar
• Koike, N., Haga, S., Ubukata, N., Sakurai, M., Shimizu, H., and Sato, A., Mutagenicity of benzene metabolites by fluctuation test, Jpn. J. Ind. Health 30, 475–480, 1988.
   PubMedGoogle Scholar
• Tsutsui, T., Hayashi, N., Maizumi, H., Huff, J., and Barrett, J. C., Benzene-, catechol-, hydroquinone-, and phenol-induced cell transformation, gene muta- tions, chromosome aberrations, aneuploidy, sister chromatid exchanges and unscheduled DNA synthe- sis in Syrian hamster embryo cells, Mutat. Res. 373, 113–123, 1997.
   PubMed Web of Science ®Google Scholar
• McGregor, D. B., Riach, C. G., Brown, A., Edwards, I., Reynolds, D., West, K., and Willington, S., Reactivity of catecholamines and related substances in the mouse lymphoma L5178Y cell assay for mu- tagens, Environ. Mol. Mutagen. 11, 523–544, 1988.
   PubMed Web of Science ®Google Scholar
• Adler, I.-D., Synopsis of the in vivo results obtained with the 10 known or suspected aneugens tested in the CEC collaborative study, Mutat. Res. 287, 131–137, 1993.
   PubMedGoogle Scholar
• Parry, J. M. and Sors, A., The detection and assess- ment of the aneugenic potential of environmental chemicals: the European Community Aneuploidy Project, Mutat. Res. 287, 3–15, 1993.
   PubMed Web of Science ®Google Scholar
• Paramentier, R. and Dustin, P., Early effects of hydroquinone on mitosis, Nature 171, 527–528, 1948.
   Google Scholar
• Rosin, A. and Doljanski, F., Effect of hydroquinone on mitosis, Nature 172, 1151, 1953.
   PubMed Web of Science ®Google Scholar
• Galloway, S. M., Armstrong, M. J., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A. D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, B. H., Resnick, M. A., Anderson, B., and Zeiger, E., Chromosome aberrations and sister chro- matid exchanges in Chinese hamster ovary cells: evalu- ations of 108 chemicals, Environ. Mol. Mutagen. 10, 1–175, 1987.
   PubMed Web of Science ®Google Scholar
• Morimoto, K. and Koizumi, A., Inhibition of rejoin- ing of radiation-induced chromosome lesions and in- duction of sister chromatid exchanges — effects of benzene or its metabolites in cultured human leuko- cytes, Jpn. J. Hum. Genet. 23, 279–281, 1978.
   Google Scholar
• Morimoto, K. and Wolff, S., Increase of sister chro- matid exchanges and perturbations of cell division kinetics in human lymphocytes by benzene metabo- lites, Cancer Res. 40, 1189–1193, 1980.
   PubMed Web of Science ®Google Scholar
• Morimoto, K., Wolff, S., and Koizumi, A., Induc- tion of sister-chromatid exchanges in human lympho- cytes by microsomal activation of benzene metabo- lites, Mutat. Res. 119, 355–360, 1983.
   PubMed Web of Science ®Google Scholar
• Morimoto, K., Takeshita, T., Takeuchi, T., Maruyama, S., Ezoe, S., Mure, K., and Inoue, C., Chromosome alterations in peripheral lymphocytes as indices of lifestyle and genotoxicity, Int. Arch. Occup. Environ. Health 65, S37–S41, 1993.
   PubMed Web of Science ®Google Scholar
• Knadle, S., Synergistic interaction between hydro- quinone and acetaldehyde in the induction of sister chromatid exchange in human lymphocytes in vitro, Cancer Res. 45, 4853–4857, 1985.
   PubMed Web of Science ®Google Scholar
• Erexson, G. L., Wilmer, J. L., and Kligerman,A. D., Sister chromatid exchange induction in human lymphocytes exposed to benzene and its metabolites in vitro, Cancer Res. 45, 2471–2477, 1985.
   PubMed Web of Science ®Google Scholar
• Pacchierotti, F., Bassani, B., Leopardi, P., and Zijno, A., Origin of aneuploidy in relation to distur- bances of cell-cycle progression. II. Cytogenetic analy- sis of various parameters in mouse bone marrow cells after colchicine or hydroquinone treatment, Mutagen- esis 6, 307–311, 1991.
   PubMed Web of Science ®Google Scholar
• Yager, J. W., Eastmond, D. A., Robertson, M. L., Paradisin, W. M., and Smith, M. T., Characteriza- tion of micronuclei induced in human lymphocytes by benzene metabolites, Cancer Res. 50, 393–399, 1990.
   PubMed Web of Science ®Google Scholar
• Migliore, L. and Nieri, M., Evaluation of twelve potential aneuploidogenic chemicals by the in vitro human lymphocyte micronucleus assay, Toxicol. In Vitro 5, 325–336, 1991.
   PubMed Web of Science ®Google Scholar
• Robertson, M. L., Eastmond, D. A., and Smith,M. T., Two benzene metabolites, catechol and hydro- quinone, produce a synergistic induction of micronu- clei and toxicity in cultured human lymphocytes, Mutat. Res. 249, 201–209, 1991.
   Google Scholar
• Vian, L., van Hummelen, P., Bichet, N., Gouy, D., and Kirsch-Volders, M., Evaluation of hydroquinone and chloral hydrate on the in vitro micronucleus test on isolated lymphocytes, Mutat. Res. 334, 1–7, 1995.
   PubMed Web of Science ®Google Scholar
• Ferguson, L. R., Morcombe, P., and Triggs, C. N., The size of cytokinesis-blocked micronuclei in hu- man peripheral blood lymphocytes as a measure of aneuploidy induction by Set A compounds in the EEC trial, Mutat. Res. 287, 101–112, 1993.
   PubMedGoogle Scholar
• Bonatti, S., Cavalieri, Z., Viaggi, S., and Abbondandolo, A., The analysis of 10 potential spindle poisons for their ability to induce CREST- positive micronuclei in human diploid fibroblasts, Mutagenesis 7, 111–114, 1992.
   PubMed Web of Science ®Google Scholar
• Glatt, H., Gemperlein, I., Setiabudi, F., Platt, K. L., and Oesch, F., Expression of xenobiotic-metaboliz- ing enzymes in propagatable cell cultures and induc- tion of micronuclei by 13 compounds, Mutagenesis 5, 241–249, 1990.
   PubMed Web of Science ®Google Scholar
• Antoccia, A., Degrassi, F., Battistoni, A., Ciliutti, P., and Tanzarella, C., In vitro micronucleus test with kinetochore staining: evaluation of test perfor- mance, Mutagenesis 6, 319–324, 1991.
   PubMed Web of Science ®Google Scholar
• Ellard, S. and Parry, E. M., Induction of micronu- clei in V79 Chinese hamster cells by hydroquinone and econazol nitrate, Mutat. Res. 287, 87–91, 1993.
   PubMedGoogle Scholar
• Seelbach, A., Fissler, B., and Madle, S., Further evaluation of a modified micronucleus assay with V79 cells for detection of aneugenic effects, Mutat. Res. 303, 163–169, 1993.
   PubMed Web of Science ®Google Scholar
• Dobo, K. I. and Eastmond, D. A., Role of oxygen radicals in the chromosomal loss and breakage in- duced by the quinone-forming compounds, hydro- quinone and tert-butylhydroquinone, Environ. Mol. Mutagen. 24, 293–300, 1994.
   PubMed Web of Science ®Google Scholar
• Tunek, A., Hogstedt, B., and Olofsson, T., Mecha- nism of benzene toxicity, effects of benzene and ben- zene metabolites on bone marrow cellularity, number of granulopoietic stem cells and frequency of micro- nuclei in mice, Chem.-Biol. Interact. 39, 129–138, 1982.
   PubMed Web of Science ®Google Scholar
• Gad-El-Karim, M. M., Ramanujam, V. S., Ahmed,A. E., and Legator, M. S., Benzene myeloclasto- genicity: a function of its metabolism, Am. J. Ind. Med. 7, 475–484, 1985.
   PubMed Web of Science ®Google Scholar
• Gad-El-Karim, M. M., Sadagopa Ramanujam,V. M., and Legator, M. S., trans, trans-Muconic acid, an open-chain urinary metabolite of benzene in mice. Quantification by high-pressure liquid chroma- tography, Xenobiotica 15, 211–220, 1985.
   PubMed Web of Science ®Google Scholar
• Ciranni, R., Barale, R., Marrazzini, A., and Loprieno, N., Benzene and the genotoxicity of its metabolites. II. The effect of the route of administra- tion on the micronuclei and bone marrow depression in mouse bone marrow cells, Mutat. Res. 209, 23–28, 1988.
   PubMed Web of Science ®Google Scholar
• Adler, I. and Kleisch, U., Comparison of single and multiple treatment regimens in the mouse bone mar- row micronucleus assay for hydroquinone (HQ) and cyclophosphamide (CP), Mutat. Res. 234, 115–123, 1990.
   PubMedGoogle Scholar
• Barale, R., Marrazzini, A., Betti, C., Vangelisti, V., Loprieno, N., and Barrai, I., Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo, Mutat. Res. 244, 15– 20, 1990.
   PubMed Web of Science ®Google Scholar
• Adler, I.-D., Kliesch, U., van Hummelen, P., and Kirsch-Volders, M., Mouse micronucleus tests with known and suspected spindle poisons: results from two laboratories, Mutagenesis 6, 47–53, 1991.
   PubMed Web of Science ®Google Scholar
• Gudi, R., Xu, J., and Thilagar, A., Assessment of the in vivo aneuploidy/micronucleus assay in mouse bone marrow cells with 16 chemicals, Environ. Mol. Mutagen. 20, 106–116, 1992.
   PubMed Web of Science ®Google Scholar
• van Hummelen, P., Deleener, A., Vanparys, P. H., and Kirsch-Volders, M., Discrimination of aneup- loidogens from clastogens by C-banding, DNA and area measurements of micronuclei from mouse bone marrow, Mutat. Res. 271, 13–28, 1992.
   PubMed Web of Science ®Google Scholar
• Chen, H. W., Tomar, R., and Eastmond, D. A., Detection of hydroquinone-induced nonrandom break- age in the centromeric heterochromatin of mouse bone marrow cells using multicolor fluorescence in situ hybridization with the mouse major and minor satel- lite probes, Mutagenesis 9, 563–569, 1994.
   PubMed Web of Science ®Google Scholar
• Marrazzini, A., Betti, C., Bernacchi, F., Barrai, I., and Barale, R., Micronucleus test and metaphase analyses in mice exposed to known and suspected spindle poisons, Mutagenesis 9, 505–515, 1994.
   PubMed Web of Science ®Google Scholar
• Marrazzini, A., Chelotti, L., Barrai, I., Loprieno, N., and Barale, R., In vivo genotoxic interactions among three phenolic benzene metabolites, Mutat. Res. 341, 29–46, 1994.
   PubMed Web of Science ®Google Scholar
• Grawe, J., Nusse, M., and Adler, I. D., Quantitative and qualitative studies of micronucleus induction in mouse erythrocytes using flow cytometry. I. Mea- surement of micronucleus induction in peripheral blood polychromatic erythrocytes by chemicals with known and suspected genotoxicity, Mutagenesis 12, 1–8, 1997.
   PubMed Web of Science ®Google Scholar
• Grawe, J., Adler, I. D., and Nusse, M., Quantitative and qualitative studies of micronucleus induction in mouse erythrocytes using flow cytometry. II. Analy- sis of micronuclei of aneugenic and clastogenic origin by dual-colour FISH on populations of bone marrow PCEs flow sorted on the basis of their relative DNA content, Mutagenesis 12, 9–16, 1997.
   PubMed Web of Science ®Google Scholar
• Ciranni, R., Barale, R., Marrazzini, A., and Loprieno, N., Benzene and the genotoxicity of its metabolites. I. Transplacental activity in mouse fe- tuses and in their dams, Mutat. Res. 208, 61–67, 1988.
   PubMed Web of Science ®Google Scholar
• Rupa, D. S., Schuler, M., and Eastmond, D. A., Detection of hyperdiploidy and breakage affecting the 1cen-1q12 region of cultured interphase human lym- phocytes treated with various genotoxic agents, Environ. Mol. Mutagen. 29, 161–167, 1997.
   PubMed Web of Science ®Google Scholar
• Miller, B.-M. and Adler, I.-D., Aneuploidy induc- tion in mouse spermatocytes, Mutagenesis, 7, 69–76, 1992.
   PubMed Web of Science ®Google Scholar
• Leopardi, P., Zijno, A., Bassani, B., and Pacchierotti, F., In vivo studies on chemically in- duced aneuploidy in mouse somatic and germinal cells, Mutat. Res. 287, 119–130, 1993.
   PubMedGoogle Scholar
• Marrazzini, A., Betti, C., Barale, R., Bernacchi, F., and Loprieno, N., Cytogenetic effects of possible aneuploidizing agents, Mutat. Res. 252, 195–196, 1991.
   Google Scholar
• Eastmond, D. A., Rupa, D. S., and Hasegawa, L. S.,Detection of hyperdiploidy and chromosome break-age in interphase human lymphocytes following ex- posure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes, Mutat. Res. 322, 9–20, 1994.
   PubMed Web of Science ®Google Scholar
• Albertini, S., Analysis of nine known or suspected spindle poisons for mitotic chromosome malsegre- gation using Saccharomyces cerevisiae D61. M, Mu- tagenesis 5, 453–459, 1990.
   Google Scholar
• Xu, W. and Adler, I.-D., Clastogenic effects of known and suspected spindle poisons studied by chromo- some analysis in mouse bone marrow cells, Mutagen- esis 5, 371–374, 1990.
   PubMed Web of Science ®Google Scholar
• Ciranni, R. and Adler, I., Clastogenic effects of hydroquinone: induction of chromosomal aberrations in mouse germ cells, Mutat. Res. 263, 223–229, 1991.
   PubMed Web of Science ®Google Scholar
• Crebelli, R., Conti, G., and Carere, A., On the mechanism of mitotic segregation induction in As- pergillus nidulans by benzene hydroxy metabolites, Mutagenesis 2, 235–238, 1987.
   PubMed Web of Science ®Google Scholar
• Crebelli, R., Conti, G., Conti, L., and Carere, A., In vitro studies with nine known or suspected spindle poisons: results in tests for chromosome malsegrega- tion in Aspergillus nidulans, Mutagenesis 6, 131–136, 1991.
   Google Scholar
• Bilimoria, M., Detection of mutagenic activity of chemicals and tobacco smoke in a bacterial system, Mutat. Res. 31, 328(abstract), 1975.
   Google Scholar
• Painter, R. B. and Howard, R., The HeLa DNA- synthesis inhibition test as a rapid screen for mu- tagenic carcinogens, Mutat. Res. 92, 427–437, 1982.
   PubMed Web of Science ®Google Scholar
• Lewis, J. G., Stewart, W., and Adams, D. O., Role of oxygen radicals in induction of DNA damage by metabolites of benzene, Cancer Res. 48, 4762–4765, 1988.
   PubMed Web of Science ®Google Scholar
• Lewis, J. G., Odom, B., and Adams, D. O., Toxic effects of benzene and benzene metabolites on mono- nuclear phagocytes, Toxicol. Appl. Pharmacol. 92, 246–254, 1988.
   PubMed Web of Science ®Google Scholar
• Maeda, M., Yamada, K., Ikeda, I., Nakajima, H., Tajima, M., and Murakami, H., Effects of phenyl compounds on proliferation and IgM production of human-human hybridoma HB4C5 cells cultured in serum-free medium, Agric. Biol. Chem. 54, 1093– 1096, 1990.
   PubMed Web of Science ®Google Scholar
• Stenius, U., Warholm, M., Rannug, A., Walles, S., Lundberg, I., and Högberg, J., The role of GSH depletion and toxicity in hydroquinone-induced de- velopment of enzyme-altered foci, Carcinogenesis 10, 593–599, 1989.
   PubMed Web of Science ®Google Scholar
• Walles, S., Mechanisms of DNA damage induced in rat hepatocytes by quinones, Cancer Lett. 63, 47–52, 1992.
   PubMed Web of Science ®Google Scholar
• Pellack-Walker, P. and Blumer, J. L., DNA dam- age in L5178Y cells following exposure to benzene metabolites, Mol. Pharmacol. 30, 42–47, 1986.
   PubMed Web of Science ®Google Scholar
• Shimada, H., Sato, T., Hattori, C., Satake, S., and Itoh, S., Induction of micronuclei by benzene and its metabolites, Mutat. Res. 216, 377(abstract), 1989.
   Google Scholar
• Sze, C. C., Shi, C. Y., and Ong, C. N., Cytotoxicity and DNA strand breaks induced by benzene and its metabolites in Chinese hamster ovary cells, J. Appl. Toxicol. 16, 259–264, 1996.
   PubMed Web of Science ®Google Scholar
• Anderson, D., Yu, T. W., and Schmezer, P., An investigation of the DNA-damaging ability of ben- zene and its metabolites in human lymphocytes, using the comet assay, Environ. Mol. Mutagen. 26, 305– 314, 1995.
   PubMed Web of Science ®Google Scholar
• Leanderson, P. and Tagesson, C., Cigarette smoke- induced DNA damage in cultured human lung cells: role of hydroxyl radicals and endonuclease activation, Chem.-Biol. Interact. 81, 197–208, 1992.
   PubMed Web of Science ®Google Scholar
• Andreoli, C., Leopardi, P., and Crebelli, R., Detec- tion of DNA damage in human lymphocytes by alka- line single cell gel electrophoresis after exposure to benzene or benzene metabolites, Mutat. Res. 377, 95– 104, 1997.
   PubMed Web of Science ®Google Scholar
• Zhang, L. P., Wang, Y. X., Shang, N., and Smith,M. T., Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lym- phocytes, Leuk. Res. 22, 105–113, 1998.
   PubMed Web of Science ®Google Scholar
• Smith, M. T. and Zhang, L. P., Biomarkers of leu- kemia risk: benzene as a model, Environ. Health Perspect. 106, 937–946, 1996.
   Web of Science ®Google Scholar
• Kappas, A., On the mechanism of induced aneup- loidy in Aspergillus nidulans and validation of tests for genomic mutations. In: Resnick, M. A. and Vig, B. K., Eds., Mechanisms of Chromosome Distribution and Aneuploidy. Alan R. Liss, Inc., New York, 1989, 377–384.
   Google Scholar
• Miller, B. M. and Adler, I. D., Suspect spindle poi- sons: analysis of c-mitotic effects in mouse bone marrow cells, Mutagenesis 4, 208–215, 1989.
   PubMed Web of Science ®Google Scholar
• Warr, T. J., Parry, E. M., and Parry, J. M., A comparison of two in vitro mammalian cell cytoge- netic assays for the detection of mitotic aneuploidy using 10 known or suspected aneugens, Mutat. Res. 287, 29–46, 1993.
   PubMedGoogle Scholar
• Hader, C., Hadnagy, W., and Seemayer, N. H., A rapid method for detection of nongenotoxic carcino- gens of environmental pollutants using synchronized V79 cells and flow cytometry, Toxicol. Lett. 88, 99– 108, 1996.
   PubMed Web of Science ®Google Scholar
• Seiler, J. P., Inhibition of testicular DNA synthesis by chemical mutagens and carcinogens. Preliminary re- sults in the validation of a novel short-term test, Mutat. Res. 46, 305–310, 1977.
   PubMed Web of Science ®Google Scholar
• Post, G. B., Snyder, R., and Kalf, G. F., Inhibition of mRNA synthesis in rabbit bone marrow nuclei in vitro by quinone metabolites of benzene, Chem.-Biol. Interact. 50, 203–211, 1984.
   PubMed Web of Science ®Google Scholar
• Post, G. B., Snyder, R., and Kalf, G. F., Inhibition of RNA synthesis and interleukin-2 production in lym- phocytes in vitro by benzene and its metabolites, hy- droquinone and p-benzoquinone, Toxicol. Lett. 29, 161–167, 1985.
   PubMed Web of Science ®Google Scholar
• Pellack-Walker, P., Walker, J. K., Evans, H. H., and Blumer, J. L., Relationship between the oxidation potential of benzene metabolites and their inhibi- tory effect on DNA synthesis in L517YS cells, Mol. Pharmacol. 28, 560–566, 1985.
   PubMed Web of Science ®Google Scholar
• Lee, E. W., Johnson, J. T., and Garner, C. D., Inhibitory effect of benzene metabolites on nuclear DNA synthesis in bone marrow cells, J. Toxicol. Environ. Health 26: 277–291, 1989.
   PubMed Web of Science ®Google Scholar
• International Programme on Chemical Safety (IPCS), Hydroquinone Health and Safety Guide, World Health Organization, Geneva, 1996.
   Google Scholar
• Irons, R. D., Neptun, D. A., and Pfeifer, R. W., Inhibition of lymphocyte transformation and microtu- bule assembly by quinone metabolites of benzene: evidence for a common mechanism, J. Reticulo- endothel. Soc. 30, 359–372, 1981.
   PubMedGoogle Scholar
• Brunner, M., Albertini, S., and Wurgler, F. E., Effects of 10 known or suspected spindle poisons in the in vitro porcine brain tubulin assembly assay, Mutagenesis 6, 65–70, 1991.
   PubMed Web of Science ®Google Scholar
• Wallin, M. and Hartley-Asp, B., Effects of potential aneuploidy inducing agents on microtubule assembly in vitro, Mutat. Res. 287, 17–22, 1993.
   PubMed Web of Science ®Google Scholar
• Li, Y. and Trush, M. A., DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation, Carcinogenesis 14, 1303–1311, 1993.
   PubMed Web of Science ®Google Scholar
• Li, Y., Kuppusamy, P., Zweier, J. L., and Trush,M. A., ESR evidence for the generation of reactive oxygen species from the copper-mediated oxidation of the benzene metabolite, hydroquinone: role in DNA damage, Chem.-Biol. Interact. 94, 101–120, 1995.
   Google Scholar
• Hiraku, Y. and Kawanishi, S., Oxidative DNA dam- age and apoptosis induced by benzene metabolites, Cancer Res. 56, 5172–5178, 1996.
   PubMed Web of Science ®Google Scholar
• Yu, T. W. and Anderson, D., Reactive oxygen spe- cies-induced DNA damage and its modification: A chemical investigation, Mutat. Res. 379, 201–210, 1997.
   PubMed Web of Science ®Google Scholar
• Lee, E. W. and Gardner, C. D., Effects of benzene on DNA strand breaks in vivo versus benzene me- tabolite-induced DNA strand breads in vitro in mouse bone marrow cells, Toxicol. Appl. Pharmacol. 108, 497–508, 1991.
   PubMed Web of Science ®Google Scholar
• Hutt, A. M. and Kalf, G. F., Inhibition of human DNA topoisomerase II by hydroquinone and p-benzo- quinone, reactive metabolites of benzene, Environ. Health Perspect. 104(Suppl. 6), 1265–1269, 1996.
   Google Scholar
• Mozhaev, E. A., Osintseva, V. P., and Arzamastsev,E. V., Hydroquinone toxicity in chronic poisoning (Russian), Farmikol. Toksikol. 29, 238–240, 1966.
   PubMedGoogle Scholar
• Rao, G. S., Siddiqui, S. M., Pandya, K. P., and Shanker, R., Relative toxicity of metabolites of ben- zene in mice, Vet. Hum. Toxicol. 30, 517–520, 1988.
   PubMedGoogle Scholar
• Kari, F. W., Bucher, J., Eustis, S. L., Haseman, J. K., and Huff, J. E., Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice, Food Chem. Toxicol. 30, 737–747, 1992.
   Google Scholar
• Boatman, R. J., English, J. C., Perry, L. G., and Bialecki, V. E., Differences in the nephrotoxicity of hydroquinone among Fischer 344 and Sprague-Dawley Rats and B6C3F1 mice, J. Toxicol. Environ. Health 47, 159–172, 1996.
   PubMed Web of Science ®Google Scholar
• Shibata, M.-A., Hirose, M., Tanaka, H., Asakawa, E., Shirai, T., and Nobuyuki, I., Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long- term hydroquinone treatment, Jpn. J. Cancer Res. 82, 1211–1219, 1991.
   PubMedGoogle Scholar
• David, R. M., English, J. C., Totman, L. C., Moyer, C., and O’Donoghue, J. L., Lack of nephrotoxicity and renal cell proliferation following subchronic der- mal application of a hydroquinone cream, Food Chem. Toxicol. 36, 609–616, 1998.
   PubMed Web of Science ®Google Scholar
• Perry, L. G., English, J. C., Vlaovic, M., Moyer, C., and Edna, J. L., Measurement of cell proliferation in the kidneys of rats after oral administration of hydro- quinone, Toxicologist 13, 394(abstract), 1993.
   Google Scholar
• Lau, S. S., Hill, B. A., Highet, R. J., and Monks,T. J., Sequential oxidation and glutathione addition to 1,4–benzoquinone: correlation of toxicity with in- creased glutathione substitution, Mol. Pharmacol. 34, 829–836, 1988.
   PubMed Web of Science ®Google Scholar
• Hill, B. A., Monks, T. J., and Lau, S., The effects of 2,3,5–(triglutathion-S-yl)hydroquinone on renal mito- chondrial respiratory function in vivo and in vitro: possible role in cytotoxicity, Toxicol. Appl. Pharmacol. 117, 165–171, 1992.
   PubMed Web of Science ®Google Scholar
• Hill, B. A., Davidson, K. L., Dulik, D. M., Monks,T. J., and Lau, S. S., Metabolism of 2–(glutathion-S- yl)hydroquinone and 2,3,5–(triglutathion-S-yl)hydro- quinone in the in situ perfused rat kidney: Relation- ship to nephrotoxicity, Toxicol. Appl. Pharmacol. 129, 121–132, 1994.
   PubMed Web of Science ®Google Scholar
• Eckert, K-G., Eyer, P., Sonnenbichler, J., and Zetl, I., Activation and detoxication of aminophenols. III. Synthesis and structural elucidation of various glu- tathione addition products to 1,4–benzoquinone, Xenobiotica 20, 351–361, 1990.
   PubMed Web of Science ®Google Scholar
• Barber, E. D., Polvino, J. M., and English, J. C., Acetylation of (L-cystein-S-yl)hydroquinone in the liver and kidney of male and female Fischer (F344) rats and male Sprague-Dawley (SD) rats, Int. Toxicol. 69, 12(abstract), 1995.
   Google Scholar
• Lau, S. S., Kleiner, H. E., and Monks, T. J., Me- tabolism as a determinant of species susceptibility to 2,3,5–(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity, Drug Metab. Disp. 23, 1136–1142, 1995.
   PubMed Web of Science ®Google Scholar
• English, J. C., Perry, L. G., Vlaovic, M., Moyer, C., and O’Donoghue, J. L., Measurement of cell prolif- eration in the kidneys of Fischer 344 and Sprague- Dawley rats after gavage administration of hydro- quinone, Fundam. Appl. Toxicol. 23, 297–406, 1994.
   Google Scholar
• O’Donoghue, J. L. and English, J. C., Some com- ments on the potential effects of hydroquinone expo- sure, Food Chem. Toxicol. 32, 863–864, 1994.
   PubMed Web of Science ®Google Scholar
• Konishi, N. and Ward, J. M., Increased levels of DNA synthesis in hyperplastic renal tubules of aging nephropathy in female F344/NCR rats, Vet. Pathol. 26, 6–10, 1989.
   PubMed Web of Science ®Google Scholar
• Hirose, M., Inoue, T., Asamoto, M., Tagawa, Y., and Ito, N., Comparison of the effects of 13 phenolic compounds in induction of proliferative lesions of the forestomach and increase in the labelling indices of the glandular stomach and urinary bladder epithelium of Syrian golden hamsters, Carcinogenesis 7, 1285– 1289, 1986.
   PubMed Web of Science ®Google Scholar
• Hirose, M., Yamaguchi, S., Fukushima, S., Hasegawa, R., Takahashu, S., and Ito, N., Promo- tion by dihydroxybenzene derivatives of N-methyl- N-nitro-N-nitrosoguanidine-induced F344 rat fore- stomach and glandular stomach carcinogenesis, Cancer Res. 49, 5143–5147, 1989.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, S., Hirose, M., Fukushima, S., Hasegawa, R., and Ito, N., Modification by catechol and resorcinol of upper digestive tract carcinogenesis in rats treated with methyl-N-amylnitrosamine, Can- cer Res. 49, 6015–6018, 1989.
   PubMed Web of Science ®Google Scholar
• Shibata, M.-A., Yamada, M., Hirose, M., Asakawa, A., Tatematsu, M., and Ito, N., Early proliferative responses of forestomach and glandular stomach of rats treated with five different phenolic antioxidants, Carcinogenesis 11, 425–429, 1990.
   PubMed Web of Science ®Google Scholar
• Altmann, H. J., Grunow, W., Wester, P. W., and Mohr, U., Induction of forestomach lesions by butylhydroxyanisole and structurally related sub- stances, Arch. Toxicol. 114–116, 1985.
   Google Scholar
• National Toxicology Program (NTP), Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71– 43–2) in F344/N Rats and B6C3F1 Mice (Gavage Studies), NTP Technical Report No. 289; Washing- ton: U.S. Department of Health and Human Services, 1986.
   Google Scholar
• Stromberg, P. C., Large granular lymphocyte leuke- mia in F344 rats. Model for human T lymphoma, malignant histiocytosis, and T-cell chronic lympho- cytic leukemia, Am. J. Pathol. 119, 517–519, 1985.
   PubMed Web of Science ®Google Scholar
• Rao, G. N., Haseman, J. K., Grumbein, S., Crawford, D. D., and Eustis, S. L., Growth, body weight, survival, and tumor trends in F344/N rats during an eleven-year period, Toxicol. Pathol. 18, 61– 70, 1990.
   PubMed Web of Science ®Google Scholar
• Roe, F. J. C. and Salaman, M. H., Further studies on incomplete carcinogenesis: Triethylene melamine (T.E. M.), 1,2–benzanthracene and β-propiolactone, as ini- tiators of skin tumor formation in the mouse, Br. J. Cancer 9, 177–203, 1955.
   PubMed Web of Science ®Google Scholar
• Boutwell, R. K. and Bosch, D. K., The tumor-pro- moting activity of phenol and related compounds for mouse skin, Cancer Res. 19, 413–424, 1959.
   PubMed Web of Science ®Google Scholar
• Van Duuren, B. L. and Goldschmidt, B. M., Cocarcinogenic and tumor-promoting agents in to- bacco carcinogenesis, J. Natl. Cancer Inst. 56, 1237– 1242, 1976.
   PubMed Web of Science ®Google Scholar
• Maruyama, H., Amanuma, T., Nakae, D., Tsutsumi, M., Kondo, S., Tsujiuchi, T., Denda, A., and Konishi, Y., Effects of catechol and its analogs on pancreatic carcinogenesis initiated by N-nitrosobis(2– oxopropyl)amine in Syrian hamsters, Carcinogenesis 12, 1331–1334, 1991.
   PubMed Web of Science ®Google Scholar
• Kurata, Y., Fukushima, S., Hasegawa, R., Hirose, M., Shibata, M.-A., Shirai, T., and Ito, N., Struc- ture-activity relations in promotion of rat urinary blad- der carcinogenesis by phenolic antioxidants, Jpn. J. Cancer Res. 81, 754–759, 1990.
   PubMedGoogle Scholar
• Miyata, Y., Fukushima, S., Hirose, M., Masui, T., and Ito, N., Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxy- butyl)nitrosamine-initiated, unilaterally ureter-ligated rats, Jpn. J. Cancer Res. 76, 828–834, 1985.
   PubMedGoogle Scholar
• Hasegawa, R., Furukawa, F., Toyoda, K., Taka- hashi, M., Hayashi, Y., Hirose, M., and Ito, N., Inhibitory effects of antioxidants on N-bis(2- hydroxypropyl)nitrosamine-induced lung carcinogen- esis in rats, Jpn. J. Cancer Res. 81, 871–877, 1990.
   PubMedGoogle Scholar
• Boyland, E., Busby, E. R., Dukes, C. R., Grover, P. L., and Manson, D., Further experiments on im- plantation of materials into the urinary bladder of mice, Br. J. Cancer 18, 575–581, 1964.
   Web of Science ®Google Scholar
• Hasegawa, R. and Ito, N., Liver medium-term bioas- say in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis, Food Chem. Toxicol. 30, 979–992, 1992.
   PubMed Web of Science ®Google Scholar
• Stenius, U., Warholm, M., and Högberg, J., Selec- tive toxicity in putative preneoplastic hepatocytes: a comparison of hydroquinone and duroquinone, Can- cer Lett. 68, 149–157, 1993.
   PubMed Web of Science ®Google Scholar
• Hagiwara, A., Kokubo, Y., Takesada, Y., Tanaka, H., Tamano, S., Hirose, M., Shirai, T., and Ito, N., Inhibitory effects of phenolic compounds on develop- ment of naturally occurring preneoplastic hepatocytic foci in long-term feeding studies using male F344 rats, Teratogen. Carcinogen. Mutagen. 16, 317–325, 1996.
   PubMedGoogle Scholar
• Delcambre, J., Weber, B., and Baron, C., Toxicity of hydroquinone (French), Revue Agressologie 3, 311– 315, 1962.
   PubMedGoogle Scholar
• Nakamura, S., The effects of oral administration of resorcin, hydroquinone and phenol on the hematopoi- etic system in mice (Japanese), Osaka-Furitsu Koshu Eisei Kenkyusho 20, 45–49, 1982.
   Google Scholar
• Mitchell, J. R., Mechanism of benzene-induced aplas- tic anemia, Fed. Proc. 30, 561(abstract), 1971.
   Google Scholar
• Snyder, R. and Kalf, G. F., A perspective on ben- zene leukemogenesis, Crit. Rev. Toxicol. 24, 177– 209, 1994.
   PubMed Web of Science ®Google Scholar
• Smith, M. T., Overview of benzene-induced aplastic anaemia, Eur. J. Haematol. 57(Suppl.), 107–110, 1996.
   Google Scholar
• Tunek, A., Olofsson, T., and Berlin, M., Toxic ef- fects of benzene and benzene metabolites on granulopoietic stem cells and bone marrow cellularity in mice, Toxicol. Appl. Pharmacol. 59, 149–156, 1981.
   PubMed Web of Science ®Google Scholar
• Wierda, D. and Irons, R. D., Hydroquinone and catechol reduce the frequency of progenitor B lym- phocytes in mouse spleen and bone marrow, Immunopharmacology 4, 41–54, 1982.
   PubMed Web of Science ®Google Scholar
• Eastmond, D. A., Smith, M. T., and Irons, R. D., An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure, Toxicol. Appl. Pharmacol. 91, 85–95, 1987.
   PubMed Web of Science ®Google Scholar
• Henschler, R., Glatt, H. R., and Heyworth, C. M., Hydroquinone stimulates granulocyte-macrophage progenitor cells in vitro and in vivo, Environ. Health Perspect. 104, 1271–1274, 1996.
   PubMed Web of Science ®Google Scholar
• Hazel, B. A. and Kalf, G. F., Induction of granulo- cytic differentiation in myeloblasts by hydroquinone, a metabolite of benzene, involves the leukotriene D4 receptor, Receptor Signal Transduction 6, 1–12, 1996.
   PubMedGoogle Scholar
• Boyd, R., Griffiths, J., Kindt, V., Snyder, R., Caro, J., and Ersley, A., Relative toxicity of five benzene metabolites on CFU-GM cultures, Toxicologist 2, 121– 122(abstract), 1982.
   Google Scholar
• Colinas, R. J., Burkart, P. T., and Lawrence, D. A., In vitro effects of hydroquinone, benzoquinone, and doxorubicin on mouse and human bone marrow cells at physiological oxygen partial pressure, Toxicol. Appl. Pharmacol. 129, 95–102, 1994.
   PubMed Web of Science ®Google Scholar
• Irons, R. D., Stillman, W. S., Colagiovanni, D. B., and Henry, V. A., Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulat- ing factor in vitro, Proc .Natl. Acad. Sci. U.S.A. 89, 3691–3695, 1992.
   PubMed Web of Science ®Google Scholar
• Irons, R. D. and Stillman, W. S., The effects of benzene and other leukaemogenic agents on haematopoietic stem and progenitor cell differentia- tion, Eur. J. Haematol. 57(Suppl.), 119–124, 1996.
   Google Scholar
• Oliveira, N. L. and Kalf, G. F., Induced differentia- tion of HL-60 promyelocytic leukemia cells to mono- cyte/macrophages is inhibited by hydroquinone, a hematotoxic metabolite of benzene, Blood 79, 627– 633, 1992.
   PubMed Web of Science ®Google Scholar
• Hazel, B. A., O’Connor, A., Niculescu, R., and Kalf, G. F., Benzene and its metabolite, hydroquinone, induce granulocytic differentiation in myeloblasts by interacting with cellular signaling pathways activated by granulocyte colony-stimulating factor, Stem Cells 13, 295–310, 1995.
   PubMed Web of Science ®Google Scholar
• Moran, J. L., Siegel, D., Sun, X. M., and Ross, D., Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells, Mol. Pharmacol. 50, 610–615, 1996.
   PubMed Web of Science ®Google Scholar
• Hazel, B. A., Baum, C., and Kalf, G. F., Hydro- quinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts, Stem Cells 14, 730–742, 1996.
   PubMed Web of Science ®Google Scholar
• Bolcsak, L. E. and Nerland, D. E., Inhibition of erythropoiesis by benzene and benzene metabolites, Toxicol. Appl. Pharmacol. 69, 363–368, 1983.
   PubMed Web of Science ®Google Scholar
• Snyder, R., Dimitriadis, E., Guy, R., Hu, P., Coo- per, K., Bauer, H., Witz, G. and Goldstein, B. D., Studies on the mechanism of benzene toxicity, Environ. Health Perspect. 82, 31–35, 1989.
   PubMed Web of Science ®Google Scholar
• Guy, R. L., Dimitriadis, E. A., Hu, P., Cooper,K. R., and Snyder, R., Interactive inhibition of erythroid 59Fe utilization by benzene metabolites in female mice, Chem.-Biol. Interact. 74, 55–62, 1990.
   PubMed Web of Science ®Google Scholar
• Guy, R. L., Hu, P., Witz, G., Goldstein, B. D., and Snyder, R., Depression of iron uptake into erythro- cytes in mice by treatment with the combined benzene metabolites p-benzoquinone, muconaldehyde and hy- droquinone, J. Appl. Toxicol. 11, 443–446, 1991.
   PubMed Web of Science ®Google Scholar
• Seidel, H. J., Barthel, E., Schafer, F., Scad, H., and Weber, L., Action of benzene metabolites on murine hematopoietic colony-forming cells in vitro, Toxicol. Appl. Pharmacol. 111, 128–131, 1991.
   PubMed Web of Science ®Google Scholar
• Brown, A., Lutton, J. D., Nelson, J., Abraham,N. G., and Levere, R. D., Microenvironmental cytokines and expression of erythroid heme metabolic enzymes, Blood Cells 13, 123–136, 1987.
   PubMedGoogle Scholar
• Neun, D. J., Penn, A., and Snyder, C. A., Evidence for strain-specific differences in benzene toxicity as a function of host target cell susceptibility, Arch. Toxicol. 66, 11–17, 1992.
   PubMed Web of Science ®Google Scholar
• Gross, S., Gruntmeir, J., Helm, K., Stillman, W., and Irons, R., The benzene metabolite, hydroquinone, alters phenotypic expression of human CD34+ cells in liquid culture, Toxicologist 36, 163(abstract), 1997.
   Google Scholar
• Greenberger, J. S., The hematopoietic microenvi- ronment, Crit. Rev. Oncol. Hematol. 11, 65–84, 1991.
   PubMed Web of Science ®Google Scholar
• Morrison, S. J., Uchida, N., and Weissman, I. L., The biology of hematopoietic stem cells, Annu. Rev. Cell Dev. Biol. 11, 35–71, 1995.
   PubMed Web of Science ®Google Scholar
• Gaido, K. and Wierda, D., In vitro effects of ben- zene metabolites on mouse bone marrow stromal cells, Toxicol. Appl. Pharmacol. 76, 45–55, 1984.
   PubMed Web of Science ®Google Scholar
• Gaido, K. W. and Wierda, D., Suppression of bone marrow stromal cell function by benzene and hydro- quinone is ameliorated by indomethacin, Toxicol. Appl. Pharmacol. 89, 378–390, 1987.
   PubMed Web of Science ®Google Scholar
• Thomas, D. J., Reasor, M. J., and Wierda, D., Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone, Toxicol. Appl. Pharmacol. 97, 440–453, 1989.
   PubMed Web of Science ®Google Scholar
• Renz, J. F. and Kalf, G. F., Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1 to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1, Blood 78, 938–944, 1991.
   PubMed Web of Science ®Google Scholar
• Miller, A. C., Schattenberg, D. G., Malkinson, A. M., and Ross, D., Decreased content of the IL-1 processing enzyme calpain in murine bone marrow- derived macrophages after treatment with the benzene metabolite hydroquinone, Toxicol. Lett. 74, 177–184, 1994.
   PubMed Web of Science ®Google Scholar
• Niculescu, R., Bradford, H. N., Colman, R. W., and Kalf, G. F., Inhibition of the conversion of pre- interleukins-1 and -1β to mature cytokines by p-benzoquinone, a metabolite of benzene, Chem.-Biol. Interact. 98, 211–222, 1995.
   PubMed Web of Science ®Google Scholar
• Kalf, G. F., Renz, J. F., and Niculescu, R., p-Ben- zoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1 and -β to active cytokines by inhibition of the processing enzymes,calpain, and interleukin-1β converting enzyme, Environ. Health Perspect. 104: 1251–1256, 1996.
   PubMed Web of Science ®Google Scholar
• Carbonnelle, P., Lison, D., LeRoy, J-Y. and Lauwerys, R., Effect of the benzene metabolite, hy- droquinone, on interleukin-1 secretion by human monocytes in vitro, Toxicol. Appl. Pharmacol. 132, 220–226, 1995.
   PubMed Web of Science ®Google Scholar
• Post, G., Snyder, R., and Kalf, G. F., Metabolism of benzene and phenol in macrophages in vitro and the inhibition of RNA synthesis by benzene metabolites, Cell Biol. Toxicol. 2, 231–246, 1986.
   PubMed Web of Science ®Google Scholar
• Smart, R. C. and Zannoni, V. G., DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of ben- zene, Mol. Pharmacol. 26, 105–111, 1984.
   PubMed Web of Science ®Google Scholar
• Schattenberg, D. G., Stillman, W. S., Gruntmeir, J. J., Helm, K. M., Irons, R. D., and Ross, D., Peroxidase activity in murine and human hematopoi- etic progenitor cells: potential relevance to benzene- induced toxicity, Mol. Pharmacol. 46, 346–351, 1994.
   PubMed Web of Science ®Google Scholar
• Wever, R., Plat, H., and Hamers, M. N., Suppres- sion of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indomethacin, FEBS Lett. 123: 327–331.
   Google Scholar
• Pirozzi, S. J., Schlosser, M. J., and Kalf, G. F., Prevention of benzene-induced myelotoxicity and pros- taglandin synthesis in bone marrow of mice by inhibi- tors of prostaglandin H synthase, Immunopharma- cology 18, 39–55, 1989.
   PubMedGoogle Scholar
• Thomas, D. J., Sadler, A., Subrahmanyam, V. V., Siegel, D., Reasor, M. J., Wierda, D., and Ross, D., Bone marrow stromal cell bioactivation and detoxifi- cation of the benzene metabolite hydroquinone: com- parison of macrophages and fibroblastoid cells, Mol. Pharmacol. 37, 255–262, 1990.
   PubMed Web of Science ®Google Scholar
• London, S. J., Lehman, T. A., and Taylor, J. A., Myeloperoxidase genetic polymorphism and lung can- cer risk, Cancer Res. 57, 5001–5003, 1997.
   PubMed Web of Science ®Google Scholar
• Meyer, K. B., Subrahmanyam, V. V., Kolachana, P., and Smith, M. T., Bioactivation and cytotoxicity of hydroquinone in human promyelocytic leukemia (HL60) cells, Toxicologist 11, 180(abstract), 1991.
   Google Scholar
• Bratton, S. B., Lau, S. S., and Monks, T. J., Iden- tification of quinol thioethers in bone marrow of hy- droquinone/phenol-treated rats and mice and their po- tential role in benzene-mediated hematotoxicity, Chem. Res. Toxicol. 10, 859–865, 1997.
   PubMed Web of Science ®Google Scholar
• Twerdok, L. E. and Trush, M. A., Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57BL/6 and DBA/2 mice, Res. Commun. Chem. Pathol. Pharmacol. 67, 375– 386, 1990.
   PubMedGoogle Scholar
• Zhu, H., Li, Y., and Trush, M.A., Differences in xenobiotic detoxifying activities between bone mar- row stromal cells from mice and rats: implications for benzene-induced hematotoxicity, J. Toxicol. Environ. Health 46, 183–201, 1995.
   PubMed Web of Science ®Google Scholar
• Twerdok, L. E., Rambish, S. J., and Trush, M. A.,Induction of quinone reductase and glutathione in bone marrow cells by 1,2–dithiole-3–thione: effect on hydroquinone-induced cytotoxicity, Toxicol. Appl. Pharmacol. 112, 273–281, 1992.
   PubMed Web of Science ®Google Scholar
• Twerdok, L. E., Rambish, S. J., and Trush, M. A., Studies with 1,2–dithiole-3–thione as a chemoprotector of hydroquinone-induced toxicity to DBA/2–derived bone marrow stromal cells, Environ. Health Perspect. 101, 172–177, 1993.
   PubMed Web of Science ®Google Scholar
• Li, Y., Lafuente, A., and Trush, M. A., Character- ization of quinone reductase, glutathione and glu- tathione S-transferase in human myeloid cell lines: induction by 1,2–dithiole-3–thione and effects on hy- droquinone-induced cytotoxicity, Life Sci. 54, 901– 916, 1994.
   PubMed Web of Science ®Google Scholar
• Rothman, N., Smith, M. T., Hayes, R. B., Traver,R. D., Hoener, B., Campleman, S., Li, G. L., Dosemeci, M., Linet, M., Zhang, L., Xi, L., Wacholder, S., Lu, W., Meyer, K. B., Titenko- Holland, N., Stewart, J. T., Yin, S., and Ross, D., Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609CT mutation and rapid fractional excretion of chlorzox- azone, Cancer Res. 57, 2839–2842, 1997.
   PubMed Web of Science ®Google Scholar
• Laskin, J. D., Rao, N. R., Punjabi, C. J., Laskin, D. L., and Synder, R., Distinct actions of benzene and its metabolites on nitric oxide production by bone marrow leukocytes, J. Leukocyte Biol. 57, 422–426, 1995.
   PubMed Web of Science ®Google Scholar
• Rao, N. R. and Snyder, R., Oxidative modifications produced in HL-60 cells on exposure to benzene metabolites, J. Appl. Toxicol. 15, 403–409, 1995.
   PubMed Web of Science ®Google Scholar
• Pfeifer, R. W. and Irons, R. D., Inhibition of lectin- stimulated lymphocyte agglutination and mitogenesis by hydroquinone: reactivity with intracellular sulfhy- dryl groups, Exp. Mol. Pathol. 35, 189–198, 1981.
   PubMed Web of Science ®Google Scholar
• Pfeifer, R. W. and Irons, R. D., Alteration of lym- phocyte function by quinones through a sulfhydryl- dependent distribution of microtubule assembly, Int.J. Immunopharmacol. 5, 463–470, 1983.
   PubMed Web of Science ®Google Scholar
• King, A. G., Landreth, K. S., and Wierda, D., Hy- droquinone inhibits bone marrow pre-B cell matura- tion in vitro, Mol. Pharmacol. 32, 807–812, 1987.
   PubMed Web of Science ®Google Scholar
• King, A. G., Landreth, K. S., and Wierda, D., Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation, J. Pharmacol. Exp. Ther. 250, 582– 590, 1989.
   PubMed Web of Science ®Google Scholar
• Lang, D. S., Meier, K. L., and Luster, M. I., Com- parative effects of immunotoxic chemicals on in vitro proliferative responses of human and rodent lympho- cytes, Fundam. Appl. Toxicol. 21, 535–545, 1993.
   PubMedGoogle Scholar
• Li, Q., Geiselhart, L., Mittler, J. N., Mudzinski,S. P., Lawrence, D. A., and Freed, B. M., Inhibition of human T lymphoblast proliferation for hydro- quinone, Toxicol. Appl. Pharmacol. 139, 317–323, 1996.
   PubMed Web of Science ®Google Scholar
• Li, Q. and Freed, B. M., HQ inhibits lymphoblast proliferation by two different mechanisms, Toxicolo- gist 36, 200(abstract), 1997.
   Google Scholar
• Li, Q. and Freed, B. M., Role of iron in hydro- quinone- and catechol-induced inhibition of IL-2–de- pendent lymphoblast proliferation, Fundam. Appl. Toxicol. 30, 4(abstract), 1996.
   Google Scholar
• Li, Q., Aubrey, M. T., Christian, T., and Freed,B. M., Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydro- quinone and catechol, Fundam. Appl. Toxicol. 38, 158–165, 1997.
   PubMedGoogle Scholar
• Li, Q., Kasten-Jolly, J., Yen, Y., and Freed, B. M., Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase, Toxicol. Appl. Pharmacol. 150, 154–157, 1988.
   Google Scholar
• Updyke, L. W., Wilson, P. S., and Wierda, D., Decreased IL-7 production by long term bone marrow cultures following exposure to quinones, Toxicologist 11, 203(abstract), 1991.
   Google Scholar
• Cheung, S. C., Newland, D. E., and Sonnenfeld, G., Inhibition of interferon gamma production by ben- zene and benzene metabolites, J. Natl. Cancer Inst. 80, 1069–1072, 1988.
   PubMedGoogle Scholar
• Cheung, S. C., Nerland, D. E., and Sonnenfeld, G., Inhibition of interferon-/β induction in L-929 cells by benzene and benzene metabolites, Oncology 46, 335–338, 1989.
   PubMed Web of Science ®Google Scholar
• Pyatt, D. W., Stillman, W. S., and Irons, R. D., Hydroquinone, a reactive metabolite of benzene, in- hibits NF-B in primary human CD4+ T lymphocytes, Toxicol. Appl. Pharmacol. 149, 178–184, 1998.
   PubMed Web of Science ®Google Scholar
• Fan, X., Hirata, Y., and Minami, M., Effect of benzene and its metabolites on natural killer activity of mouse spleen cells in vitro, Jpn. J. Ind. Health, 31, 330–334, 1989.
   PubMedGoogle Scholar
• Manning, B. W., Adams, D. O., and Lewis, J. G., Effects of benzene metabolites on receptor-mediated phagocytosis and cytoskeletal integrity in mouse peri- toneal macrophages, Toxicol. Appl. Pharmacol. 126, 214–223, 1994.
   PubMed Web of Science ®Google Scholar
• Medinsky, M. A., Kenyon, E. M., Seaton, M. J., and Schlosser, P. M., Mechanistic considerations in benzene physiological model development, Environ. Health Perspect. 104, 1399–1404, 1996.
   PubMed Web of Science ®Google Scholar
• Burgaz, S., Ozcan, M., Ozkul, A., and Karakaya,A. E., Effect of hydroquinone (HQ) on the develop- ment of chick embryos, Drug Chem. Toxicol. 17, 163–174, 1994.
   PubMed Web of Science ®Google Scholar
• Chapman, D. E., Namkung, M. J., and Juchau,M. R., Benzene and benzene metabolites as embryo- toxic agents: effects on cultured rat embryos, Toxicol. Appl. Pharmacol. 128: 129–137, 1994.
   PubMed Web of Science ®Google Scholar
• Oglesby, L. A., Ebron-McCoy, M. T., Logsdon,T. R., Copeland, F., Beyer, P. E., and Kavlock,R. J., In vitro embryotoxicity of a series of para- substituted phenols: structure, activity, and correla- tion with in vivo data, Teratology 45, 11–33, 1992.
   PubMedGoogle Scholar
• Telford, I. R., Woodruff, C. S., and Linford, R. H., Fetal resorption in the rat as influenced by certain antioxidants, Am. J. Anat. 26, 195–200, 1962.
   Google Scholar
• Racz, G., Fuzi, J., Kemeny, G., and Kisgyorgy, Z., The effect of hydroquinone and phlorizin on the sexual cycle of white rats (Russian), Orvosi Szemle, 5, 65– 67, 1958.
   Google Scholar
• Rosen, F. and Millman, N., Anti-gonadotropic ac- tivities of quinones and related compounds, Endocri- nology 57, 466–471, 1955.
   PubMedGoogle Scholar
• Skalka, P., Influence of hydroquinone on the fertility of male rats (Czech), Sb. Vys. Sk. Zemed. B, 12, 491– 494, 1964.
   Google Scholar
• Ames, S. R., Ludwig, M. I., Swanson, W. J., and Harris, P. L., Effect of DPPD, methylene blue, BHT, and hydroquinone on reproductive process in the rat, Proc. Soc. Exp. Biol. Med. 93, 39–42, 1956.
   PubMed Web of Science ®Google Scholar
• Kavlock, R. J., Oglesby, L. A., Hall, L. L., Fisher,H. L., Copeland, F., Logsdon, T., and Ebron- McCoy, M., In vivo and in vitro structure-dosimetry- activity relationships of substituted phenols in devel- opmental toxicity assays, Fundam. Appl. Toxicol. 16, 225229, 1990.
   Google Scholar
• Cosmetic, Toiletry, and Fragrance Association (CTFA), Dermal Teratology Study in Albino Female Sprague-Dawley Rats, Washington: Cosmetics, Toi- letry, and Fragrance Manufacturers, 1980; Study Project TR-01–80.
   Google Scholar
• Murphy, S. J., Schroeder, R. E., Blacker, A. M., Krasavage, W. J., and English, J. C., A study of developmental toxicity of hydroquinone in the rabbit, Fundam. Appl. Toxicol. 19, 214–221, 1992.
   PubMedGoogle Scholar
• Blacker, A. M., Schroeder, R. E., English, J. C., Murphy, S. J., Krasavage, W. J., and Simon, G. S., A two-generation reproduction study with hydro- quinone in rats, Fundam. Appl. Toxicol. 21, 420–424, 1993.
   PubMedGoogle Scholar
• Nowak, A. K., Shilkin, K. B., and Jeffrey, G. P., Darkroom hepatitis after exposure to hydroquinone, Lancet 345, 1187, 1995.
   PubMed Web of Science ®Google Scholar
• Care, G. L., Darkroom exposure to hydroquinone, Lancet 347, 121, 1996.
   PubMed Web of Science ®Google Scholar
• Sterner, J. H., Oglesby, F. L., and Anderson, B., Quinone vapors and their harmful effects. I. Corneal and conjunctival injury, J. Ind. Hyg. Toxicol. 29, 60– 73, 1947.
   PubMedGoogle Scholar
• Pifer, J. W., Hearne, F. T., Friedlander, B. R., and McDonough, J. R., Mortality study of men employed at a large chemical plant, 1972 through 1982, J. Occup. Med. 28, 438–444, 1986.
   PubMedGoogle Scholar
• Pifer, J. W., Hearne, F. T., Swanson, F. A., and O’Donoghue, J. L., Mortality study of employees engaged in the manufacture and use of hydroquinone, Int. Arch. Occup. Environ. Health, 67, 267–280, 1995.
   PubMed Web of Science ®Google Scholar
• Choudat, D., Neukirch, F., Brochard, P., Barrat, G., Marsac, J., Conso, F., and Philbert, M., Allergy and occupational exposure to hydroquinone and to methionine, Br. J. Ind. Med. 45, 376–380, 1988.
   PubMedGoogle Scholar
• Nielsen, H., Henriksen, L., and Olsen, J. H., Malig- nant melanoma among lithographers, Scand. J. Work Environ. Health, 22, 108–111, 1996.
   PubMed Web of Science ®Google Scholar
• Austin, D. F. and Reynolds, P., Investigation of an excess of melanoma among employees of the lawrenc livermore national laboratory, Am. J. Epidemiol., 145, 524–531, 1997.
   PubMed Web of Science ®Google Scholar
• Von Oettingen, W. F., Hydroquinone, in Phenol and Its Derivatives: The Relation Between Their Chemi- cal Constitution and Their Effect on the Organism, Washington: U.S. Public Health Service, 1949, 145– 166.
   Google Scholar
• Grant, W. M. and Schuman, J. S., Toxicology of the Eye, Springfield, 4th ed., Charles C Thomas, 1993, 801–804.
   Google Scholar
• Oglesby, F. L. and Raleigh, R. L., Eye Injury Asso- ciated with Exposure to Hydroquinone and Quinone, 2nd ed., Tennessee Eastman Company, Kingsport, 1973.
   Google Scholar
• Anderson, B., Corneal and conjunctival pigmenta- tion among workers engaged in manufacture of hyd- roquinone, Arch. Ophthalmol. 38, 812–826, 1947.
   Google Scholar
• Naumann, G., Corneal damage in hydroquinone work- ers, Arch. Ophthalmol. 76, 189–194, 1966.
   PubMedGoogle Scholar
• Anderson, B., Corneal changes from quinone-hydro- quinone exposure, Arch. Ophthalmol. 59, 495–501, 1958.
   PubMedGoogle Scholar
• Hughes, W., The tolerance of rabbit cornea for vari- ous chemical substances, Bull. Johns Hopkins Hosp. 82, 338–349, 1948.
   PubMedGoogle Scholar
• Ferraris de Gaspare, P. F., Experimental studies on keratoconjunctivitis from hydroquinone (Italian), Boll. Oculist. 28, 361–367, 1949.
   Google Scholar
• Oettel, H., The toxicology of hydroquinone (Ger- man), Arch. Exp. Pathol. Pharmakol. 183, 319–362, 1936.
   Google Scholar
• Martin, G. J. and Ansbacher, S., Confirmatory evi- dence of the chromotrichial activity of p-aminoben- zoic acid, J. Biol. Chem. 138, 441, 1941.
   Google Scholar
• Chavin, W., Effects of hydroquinone and of hypo- physectomy upon the pigment cells of black goldfish, J. Pharmacol. Exp. Ther. 142, 275–290, 1963.
   PubMed Web of Science ®Google Scholar
• Chavin, W. and Schlesinger, W., Some potent mela- nin depigmentary agents in the black goldfish, Naturwissenschaftten 53, 413–414, 1966.
   PubMedGoogle Scholar
• Bleehen, S. S., Pathak, M. A., Hori, Y., and Fitzpatrick, T. B., Depigmentation of skin with 4–isopropylcatechol, mercaptoamines, and other com- ponents, J. Invest. Dermatol. 50, 103–117, 1968.
   PubMed Web of Science ®Google Scholar
• Jimbow, K., Obata, K., Pathak, M. A., and Fitzpatrick, T. B., Mechanism of depigmentation by hydroquinone, J. Invest. Dermatol. 62, 436–449, 1974.
   PubMed Web of Science ®Google Scholar
• Lerner, A. B., Fitzpatrick, T. B., Calkins, E., and Summerson, W. H., Mammalian tyrosinase action of substances structurally related to tyrosine, J. Biol. Chem. 178, 185–195, 1951.
   Google Scholar
• Denton, C., Lerner, A. B., and Fitzpatrick, T. B., Inhibition of melanin formation by chemical agents, J. Invest. Dermatol. 18, 119–135, 1952.
   PubMed Web of Science ®Google Scholar
• Iijima, S. and Watanabe, K., Studies on Dopa reac- tion. II. Effect of chemicals on the reaction, J. Invest. Dermatol. 28, 1–4, 1959.
   Web of Science ®Google Scholar
• Chen, Y. M. and Chavin, W., Hydroquinone activa- tion and inhibition of skin tyrosinase, Pigment Cell, 3, 105–112, 1976.
   Google Scholar
• Passi, S. and Nazzaro-Porro, M., Molecular basis of substrate and inhibitory specificity of tyrosinase: phe- nolic compounds, Br. J. Dermatol. 104, 659–665, 1981.
   PubMed Web of Science ®Google Scholar
• Bolognia, J. L., Sodi, S. A., Osber, M. P., and Pawelek, J. M., Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine, Br. J. Dermatol. 133, 349–357, 1995.
   PubMed Web of Science ®Google Scholar
• Hu, F., The influence of certain hormones and chemi- cals on mammalian pigment cells, J. Invest. Dermatol. 46, 117–124, 1966.
   PubMed Web of Science ®Google Scholar
• Abramowitz, J. and Chavin, W., Acute effects of two melanocytolytic agents, hydroquinone and β- mercaptoethanolamine, upon tyrosinase activity and cyclic nucleotide levels in murine melanomas, Chem.- Biol. Interact. 32, 195–208, 1980.
   PubMed Web of Science ®Google Scholar
• Penney, K. B., Smith, C. J., and Allen, J. C., Depigmenting action of hydroquinone depends on disruption of fundamental cell processes, J. Invest. Dermatol. 82: 308–310, 1984.
   PubMed Web of Science ®Google Scholar
• Smith, C. J., O’Hare, K. B., and Allen, J. C., Selec- tive cytotoxicity of hydroquinone for melanocyte-de- rived cells is mediated by tyrosinase activity but inde- pendent of melanin content, Pigment Cell Res. 1, 386–389, 1988.
   PubMedGoogle Scholar
• Passi, S., Picardo, M., and Nazzaro-Porro, M., Com- parative cytotoxicity of phenols in vitro, Biochem. J. 245, 537–542, 1987.
   PubMedGoogle Scholar
• Picardo, M., Cannistraci, C., De Luca, C., Zompetta, C., and Santucci, B., Effect of para group substances on human keratinocytes in culture, Con- tact Dermatitis 23, 236, 1990.
   Google Scholar
• Chavin, W., Jelonek, E. J., Reed, A. H., and Binder,L. R., Survival of mice receiving melanoma trans- plants is promoted by hydroquinone, Science 208, 408–410, 1980.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick, T. B., Arndt, K. A., El Mofty, A. M., and Pathak, M. A., Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo, Arch. Dermatol. 93, 589–600, 1966.
   PubMedGoogle Scholar
• Spencer, M., Hydroquinone bleaching, Arch. Dermatol. 84, 131–134, 1961.
   Google Scholar
• Spencer, M. C., Topical use of hydroquinone for depigmentation, JAMA 194, 114–116, 1965.
   Web of Science ®Google Scholar
• Arndt, K. A. and Fitzpatrick, T. B., Topical use of hydroquinone as a depigmenting agent, JAMA 194, 117–119, 1965.
   Web of Science ®Google Scholar
• Bentley-Phillips, B. and Bayles, M. A. H., Cutane- ous reactions to topical application of hydroquinone, South African Med. J. 49, 1391–1395, 1975.
   PubMed Web of Science ®Google Scholar
• Kligman, A. M. and Willis, I., A new formula for depigmenting human skin, Arch. Dermatol. 111, 40–hypomelanosis: hyperpigmentation following reactions to hydroquinones, Br. J. Dermatol. 90, 232–233, 1974.
   PubMed Web of Science ®Google Scholar
• Findlay, G. H., Morrison, J. G. L., and Simson,I. W., Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams, Br. J. Dermatol. 93, 613–622, 1975.
   PubMed Web of Science ®Google Scholar
• Findlay, G. H. and De Beer, H. A., Chronic hydro- quinone poisoning of the skin from skin-lightening cosmetics, South African Med. J. 57, 187–190, 1980.
   PubMed Web of Science ®Google Scholar
• Burke, P. A. and Maibach, H. I., Exogenous ochro- nosis: an overview, J. Dermatol. Treat. 8, 21–26, 1997.
   Web of Science ®Google Scholar
• Hardwick, N., Van Gelder, J. W., Van der Merwe,C. A., and Van der Merwe, M. P., Exogenous ochro- nosis: an epidemiological study, Br. J. Dermatol. 120, 229–238, 1989.
   PubMed Web of Science ®Google Scholar
• Findlay, G. H., Ochronosis following skin bleaching with hydroquinone, J. Am. Acad. Dermatol. 6, 1092– 1093, 1982.
   PubMed Web of Science ®Google Scholar
• Godlee, F., Skin lighteners cause permanent damage, Br. Med. J. 305, 333, 1992.
   Google Scholar
• Williams, H., Skin lightening creams containing hy- droquinone, Br. Med. J. 305, 903–904, 1992.
   PubMed Web of Science ®Google Scholar
• Cullison, D., Abele, D. C., and O’Quinn, J. L., Localized exogenous ochronosis, J. Am. Acad. Dermatol. 8, 882–889, 1983.
   PubMed Web of Science ®Google Scholar
• Hoshaw, R. A., Zimmerman, K. G., and Menter, A., Ochronosislike pigmentation from hydroquinone bleaching creams in American blacks, Arch. Dermatol. 121, 105–108, 1985.
   PubMedGoogle Scholar
• Penneys, N. S., Ochronosislike pigmentation from hydroquinone bleaching creams, Arch. Dermatol. 121: 1239–1240, 1985.
   PubMedGoogle Scholar
• Connor, T. and Braunstein, B., Hyperpigmentation following the use of bleaching creams, Arch. Dermatol. 123, 105–106, 1987.
   PubMedGoogle Scholar
• Lawrence, N., Bligard, C. A., Reed, R., and Perret,W. J., Exogenous ochronosis in the United States, J. Am. Acad. Dermatol. 18, 1207–1212, 1988.
   PubMed Web of Science ®Google Scholar
• Mahe, A., Blanc, L., Halna, J. M., Keita, S., Sanogo, T., and Bobin, P., An epidemiologic survey on the cosmetic use of bleaching agents by the women of Bamako (Mali) (French), Ann. Dermatol. Venereol. 120, 870–873, 1993.
   PubMed Web of Science ®Google Scholar
• Sylla, R., Diouf, A., Niane, B., Ndiaye, B., Guisse,M. B., Diop, A., Ciss, M., and Ba, D., Artificial depigmentation practice of the skin in women of Dakar and analytical study of the cosmetic products used (French), Dakar Med. 39, 223–226, 1994.
   PubMedGoogle Scholar
• Garcia, R. L., White, J. W., and Willis, W. F., Hydroquinone nail pigmentation, Arch. Dermatol. 114, 1402–1403, 1978.
   PubMedGoogle Scholar
• Mann, R. J. and Harman, R. R. M., Nail staining due to hydroquinone skin-lightening creams, Br. J. Dermatol. 108, 363–365, 1983.
   PubMed Web of Science ®Google Scholar
• Duffield, J., Depigmentation of skin by quinol and its monobenzyl ether, Lancet I, 1164, 1952.
   Google Scholar
• Frenk, E. and Loi-Zedda, P., Occupational depig- mentation due to a hydroquinone-containing photo- graphic developer, Contact Dermatitis 6, 238–239, 1980.
   PubMed Web of Science ®Google Scholar
• Kersey, P. and Stevenson, C. J., Vitiligo and occu- pational exposure to hydroquinone from servicing self- photographing machines, Contact Dermatitis 7, 285– 287, 1981.
   PubMed Web of Science ®Google Scholar
• Fisher, A. A., Can bleaching creams containing 2% hydroquinone produce leukoderma? J. Am. Acad. Dermatol. 7, 134, 1982.
   Web of Science ®Google Scholar
• Liden, C., Occupational dermatoses at a film labora- tory, Contact Dermatitis 10, 77–87, 1984.
   PubMed Web of Science ®Google Scholar
• Liden, C., Occupational dermatoses at a film labora- tory. Follow-up after modernization, Contact Derma- titis 20, 191–200, 1989.
   PubMed Web of Science ®Google Scholar
• Hull, P. R. and Procter, P. R., The melanocyte: an essential link in hydroquinone-induced ochronosis, J. Am. Acad. Dermatol. 22, 529–531, 1990.
   PubMed Web of Science ®Google Scholar
• Engasser, P. G., Ochronosis caused by bleaching creams, J. Am. Acad. Dermatol. 10, 1073, 1984.
   PubMed Web of Science ®Google Scholar
• Phillips, J. I., Isaacson, C., and Carman, H., Ochro- nosis in black South Africans who used skin lighten- ers, Am. J. Dermatopathol. 8, 14–21, 1986.
   PubMed Web of Science ®Google Scholar
• O’Donoghue, M. N., Lynfield, Y. L., and Derbes, V., Ochronosis due to hydroquinone, J. Am. Acad. Dermatol. 8, 123, 1983.
   PubMed Web of Science ®Google Scholar
• Brauer, E. W., Safety of over-the-counter hydro- quinone bleaching creams, Arch. Dermatol. 121, 1239, 1985.
   PubMedGoogle Scholar
• Medinsky, M. A., Schlosser, P. M., and Bond, J. A.,Critical issues in benzene toxicity and metabolism the effects of interactions with other organic chemi- cals on risk assessment, Environ. Health Perspect. 102, 119–124, 1994.
   PubMed Web of Science ®Google Scholar
• Trush, M. A., Twerdok, L. E., Rembish, S. J., Zhu, H., and Li, Y., Analysis of target cell susceptibility as a basis for the development of a chemoprotective strategy against benzene-induced hematotoxicities, Environ. Health Perspect. 104, 1227–1234, 1996.
   PubMed Web of Science ®Google Scholar
• Rickert, D. F., Baker, T. S., Bus, J. S., Barrow, C. S., and Irons, R. D., Benzene disposition in the rat after exposure by inhalation, Toxicol. Appl. Pharmacol. 49, 417–423, 1979.
   PubMed Web of Science ®Google Scholar
• Hedli, C. C., Snyder, R., and Witmer, C. M., Bone marrow DNA adducts and bone marrow cellularity following treatment with benzene metabolites in vivo. In: Witmer, C. M., Ed., Biological Reactive Interme- diates. Plenum Press, New York, 1990, 745–748.
   Google Scholar
• Laskin, D. L., MacEachern, L., and Snyder, R., Activation of bone marrow phagocytes following ben- zene treatment of mice, Environ. Health Perspect. 82, 75–79, 1989.
   PubMed Web of Science ®Google Scholar
• Kettle, A. J. and Winterbourn, C. C., Oxidation of hydroquinone by myeloperoxidase, J. Biol. Chem. 267, 8319–8324, 1992.
   PubMed Web of Science ®Google Scholar
• Subrahmanyam, V. V., Kolachana, P., and Smith,M. T., Metabolism of hydroquinone by human myeloperoxidase: Mechanisms of stimulation by other phenolic compounds, Arch. Biochem. Biophys. 286, 76–84, 1991.
   PubMed Web of Science ®Google Scholar
• Medinsky, M. A., Kenyon, E. M., and Schlosser,P. M., Benzene: a case study in parent chemical and metabolite interactions, Toxicology 105, 225–233, 1995.
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Cooperation and De- velopment (OECD), Final SIAR (SIDS Initial As- sessment Report): Hydroquinone, Paris: OECD, 1997.
   Google Scholar